UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark one)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June 26,~~September 25, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-50307

FormFactor, Inc.

(Exact name of registrant as specified in its charter)


Delaware						13-3711155
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

7005 Southfront Road, Livermore, California 94551

(Address of principal executive offices, including zip code)

(925) 290-4000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.001 par value

FORM

Nasdaq Global Market

______________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of the Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):


Large Accelerated Filer	☒	Accelerated Filer	☐

Non-accelerated Filer	☐	Smaller Reporting Company	☐

Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~July 27,~~October 28, 2021, ~~77,674,960~~78,207,417 shares of the registrant’s common stock, par value $0.001 per share, were outstanding.

FORMFACTOR, INC.

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED ~~JUNE 26,~~SEPTEMBER 25, 2021

INDEX


Part I.	Financial Information

Item 1.	Financial Statements (Unaudited):

	Condensed Consolidated Balance Sheets as of ~~June~~September 2 65 , 2021 and December 26, 2020	3

	Condensed Consolidated Statements of Income for the three and ~~and six~~ nine months ended ~~June~~September 2 65 , 2021 and ~~June~~September 2 76 , 2020	4

	Condensed Consolidated Statements of Comprehensive Income for the three and ~~and six~~ nine months ended ~~June~~September 2 65 , 2021 and ~~June~~September 2 76 , 2020	5

	Condensed Consolidated Statement of Stockholders' Equity for the three and ~~and six~~ nine months ended ~~June~~September 2 65 , 2021 and ~~June~~September 2 76 , 2020	6

	Condensed Consolidated Statements of Cash Flows for the ~~six~~nine months ended ~~June~~September 2 65 , 2021 and ~~June~~September 2 76 , 2020	8

	Notes to Condensed Consolidated Financial Statements	10

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2524

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3635

Item 4.	Controls and Procedures	3635

Part II.	Other Information	3635



Item 1A.	Risk Factors	3635

~~Item 2.~~	~~Unregistered Sales of Equity Securities and use of proceeds~~	37







Item 6.	Exhibits	3836

Signatures		3937

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

FORMFACTOR, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)


		June 26, 2021		December 26, 2020			September 25, 2021		December 26, 2020
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	160,273	$	187,225	Cash and cash equivalents	$	153,781	$	187,225
Marketable securities	Marketable securities	95,962		67,810		Marketable securities	110,898		67,810
Accounts receivable, net of allowance for doubtful accounts of $217 and $248		108,265		107,603
Accounts receivable, net of allowance for doubtful accounts of $214 and $248						Accounts receivable, net of allowance for doubtful accounts of $214 and $248	105,807		107,603
Inventories, net	Inventories, net	111,890		99,229		Inventories, net	115,104		99,229
Restricted cash	Restricted cash	1,857		1,904		Restricted cash	2,019		1,904
Prepaid expenses and other current assets	Prepaid expenses and other current assets	19,244		23,303		Prepaid expenses and other current assets	18,892		23,303
Total current assets	Total current assets	497,491		487,074		Total current assets	506,501		487,074
Restricted cash	Restricted cash	1,836		1,969		Restricted cash	1,674		1,969
Operating lease, right-of-use-assets	Operating lease, right-of-use-assets	38,485		30,756		Operating lease, right-of-use-assets	36,669		30,756
Property, plant and equipment, net of accumulated depreciation	Property, plant and equipment, net of accumulated depreciation	125,348		104,103		Property, plant and equipment, net of accumulated depreciation	140,098		104,103
Goodwill	Goodwill	214,548		212,761		Goodwill	213,293		212,761
Intangibles, net	Intangibles, net	41,913		59,147		Intangibles, net	39,195		59,147
Deferred tax assets	Deferred tax assets	66,945		66,242		Deferred tax assets	67,231		66,242
Other assets	Other assets	1,980		1,165		Other assets	1,930		1,165
Total assets	Total assets	$	988,546	$	963,217	Total assets	$	1,006,591	$	963,217

LIABILITIES AND STOCKHOLDERS’ EQUITY	LIABILITIES AND STOCKHOLDERS’ EQUITY					LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	62,445	$	62,045	Accounts payable	$	64,925	$	62,045
Accrued liabilities	Accrued liabilities	51,487		55,342		Accrued liabilities	54,625		55,342
Current portion of term loans, net of unamortized issuance costs	Current portion of term loans, net of unamortized issuance costs	9,356		9,516		Current portion of term loans, net of unamortized issuance costs	9,213		9,516
Deferred revenue	Deferred revenue	22,655		20,964		Deferred revenue	23,275		20,964
Operating lease liabilities	Operating lease liabilities	7,908		6,704		Operating lease liabilities	7,962		6,704
Total current liabilities	Total current liabilities	153,851		154,571		Total current liabilities	160,000		154,571
Term loans, less current portion, net of unamortized issuance costs	Term loans, less current portion, net of unamortized issuance costs	20,123		24,978		Term loans, less current portion, net of unamortized issuance costs	17,742		24,978
Deferred tax liabilities	Deferred tax liabilities	4,613		5,346		Deferred tax liabilities	4,264		5,346
Long-term operating lease liabilities	Long-term operating lease liabilities	34,211		27,996		Long-term operating lease liabilities	32,401		27,996
Other liabilities	Other liabilities	6,201		6,242		Other liabilities	5,794		6,242
Total liabilities	Total liabilities	218,999		219,133		Total liabilities	220,201		219,133

Stockholders’ equity:	Stockholders’ equity:					Stockholders’ equity:

Common stock, $0.001 par value:	Common stock, $0.001 par value:					Common stock, $0.001 par value:
250,000,000 shares authorized; 77,454,800 and 77,437,997 shares issued and outstanding		77		78
250,000,000 shares authorized; 78,207,219 and 77,437,997 shares issued and outstanding						250,000,000 shares authorized; 78,207,219 and 77,437,997 shares issued and outstanding	78		78

Additional paid-in capital	Additional paid-in capital	894,062		903,838		Additional paid-in capital	892,303		903,838
Accumulated other comprehensive income	Accumulated other comprehensive income	3,596		5,886		Accumulated other comprehensive income	1,700		5,886
Accumulated deficit	Accumulated deficit	(128,188)		(165,718)		Accumulated deficit	(107,691)		(165,718)
Total stockholders’ equity	Total stockholders’ equity	769,547		744,084		Total stockholders’ equity	786,390		744,084
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	988,546	$	963,217	Total liabilities and stockholders’ equity	$	1,006,591	$	963,217

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts)

(Unaudited)


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		June 26, 2021		June 27, 2020		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Revenues	Revenues	$	188,076	$	157,824	$	374,712	$	318,577	Revenues	$	189,964	$	177,996	$	564,676	$	496,573
Cost of revenues	Cost of revenues	111,793		91,657		221,723		185,020		Cost of revenues	109,745		101,247		331,468		286,267
Gross profit	Gross profit	76,283		66,167		152,989		133,557		Gross profit	80,219		76,749		233,208		210,306
Operating expenses:	Operating expenses:									Operating expenses:
Research and development	Research and development	25,454		20,919		49,500		42,186		Research and development	26,026		22,878		75,526		65,064
Selling, general and administrative	Selling, general and administrative	30,479		22,755		60,494		50,448		Selling, general and administrative	30,940		31,834		91,434		82,282
Total operating expenses	Total operating expenses	55,933		43,674		109,994		92,634		Total operating expenses	56,966		54,712		166,960		147,346
Operating income	Operating income	20,350		22,493		42,995		40,923		Operating income	23,253		22,037		66,248		62,960
Interest income	Interest income	148		376		342		1,061		Interest income	121		249		463		1,310
Interest expense	Interest expense	(116)		(171)		(296)		(489)		Interest expense	(151)		(193)		(447)		(682)
Other expense, net	Other expense, net	(194)		(67)		(22)		(158)		Other expense, net	58		299		36		141
Income before income taxes	Income before income taxes	20,188		22,631		43,019		41,337		Income before income taxes	23,281		22,392		66,300		63,729
Provision for income taxes		2,283		2,162		5,489		4,978
Provision (benefit) for income taxes										Provision (benefit) for income taxes	2,784		(499)		8,273		4,479
Net income	Net income	$	17,905	$	20,469	$	37,530	$	36,359	Net income	$	20,497	$	22,891	$	58,027	$	59,250
Net income per share:	Net income per share:									Net income per share:
Basic	Basic	$	0.23	$	0.27	$	0.48	$	0.48	Basic	$	0.26	$	0.30	$	0.75	$	0.78
Diluted	Diluted	$	0.23	$	0.26	$	0.47	$	0.46	Diluted	$	0.26	$	0.29	$	0.73	$	0.75
Weighted-average number of shares used in per share calculations:	Weighted-average number of shares used in per share calculations:									Weighted-average number of shares used in per share calculations:
Basic	Basic	77,463		76,275		77,530		76,140		Basic	77,869		77,029		77,643		76,436
Diluted	Diluted	79,466		78,861		79,621		78,710		Diluted	79,029		78,809		79,190		78,534

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		June 26, 2021		June 27, 2020		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Net income	Net income	$	17,905	$	20,469	$	37,530	$	36,359	Net income	$	20,497	$	22,891	$	58,027	$	59,250
Other comprehensive income (loss), net of tax:	Other comprehensive income (loss), net of tax:									Other comprehensive income (loss), net of tax:
Translation adjustments and other	Translation adjustments and other	632		763		(1,747)		364		Translation adjustments and other	(1,511)		1,867		(3,258)		2,231
Unrealized gains (losses) on available-for-sale marketable securities	Unrealized gains (losses) on available-for-sale marketable securities	(97)		524		(228)		497		Unrealized gains (losses) on available-for-sale marketable securities	(62)		(148)		(290)		349
Unrealized gains (losses) on derivative instruments	Unrealized gains (losses) on derivative instruments	(89)		80		(315)		256		Unrealized gains (losses) on derivative instruments	(323)		302		(638)		558
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax	446		1,367		(2,290)		1,117		Other comprehensive income (loss), net of tax	(1,896)		2,021		(4,186)		3,138
Comprehensive income	Comprehensive income	$	18,351	$	21,836	$	35,240	$	37,476	Comprehensive income	$	18,601	$	24,912	$	53,841	$	62,388

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands, except shares)

(Unaudited)


																	Shares of Common Stock	Common Stock		Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total
		Shares of Common Stock	Common Stock		Shares of Treasury Stock	Treasury Stock		Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total
		Six Months Ended June 26, 2021															Nine Months Ended September 25, 2021
Balances, December 26, 2020	Balances, December 26, 2020	77,437,997	$	78	0	$	0	$	903,838	$	5,886	$	(165,718)	$	744,084	Balances, December 26, 2020	77,437,997	$	78	$	903,838	$	5,886	$	(165,718)	$	744,084
Issuance of common stock under the Employee Stock Purchase Plan	Issuance of common stock under the Employee Stock Purchase Plan	228,784	—		—	—		5,065		—		—		5,065		Issuance of common stock under the Employee Stock Purchase Plan	378,584	—		9,809		—		—		9,809
Issuance of common stock pursuant to exercise of options	Issuance of common stock pursuant to exercise of options	100,000	—		—	—		844		—		—		844		Issuance of common stock pursuant to exercise of options	100,000	—		844		—		—		844
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	308,219	—		—	—		(5,261)		—		—		(5,261)		Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	910,838	1		(19,602)		—		—		(19,601)
Purchase and retirement of common stock through repurchase program	Purchase and retirement of common stock through repurchase program	(620,200)	(1)		—	—		(23,950)		—		—		(23,951)		Purchase and retirement of common stock through repurchase program	(620,200)	(1)		(23,950)		—		—		(23,951)
Stock-based compensation	Stock-based compensation	—	—		—	—		13,526		—		—		13,526		Stock-based compensation	—	—		21,364		—		—		21,364
Other comprehensive loss	Other comprehensive loss	—	—		—	—		—		(2,290)		—		(2,290)		Other comprehensive loss	—	—		—		(4,186)		—		(4,186)
Net income	Net income	—	—		—	—		—		—		37,530		37,530		Net income	—	—		—		—		58,027		58,027
Balances, September 25, 2021																Balances, September 25, 2021	78,207,219	$	78	$	892,303	$	1,700	$	(107,691)	$	786,390

																	Three Months Ended September 25, 2021
Balances, June 26, 2021	Balances, June 26, 2021	77,454,800	$	77	0	$	0	$	894,062	$	3,596	$	(128,188)	$	769,547	Balances, June 26, 2021	77,454,800	$	77	$	894,062	$	3,596	$	(128,188)	$	769,547
Issuance of common stock under the Employee Stock Purchase Plan																Issuance of common stock under the Employee Stock Purchase Plan	149,800	—		4,744		—		—		4,744
		Three Months Ended June 26, 2021
Balances, March 27, 2021		77,758,530	$	78	(136,402)	$	(5,738)	$	915,136	$	3,150	$	(146,093)	$	766,533
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax																Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	602,619	1		(14,341)		—		—		(14,340)

Issuance of common stock pursuant to exercise of options		50,000	—		—	—		422		—		—		422
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax		266,470	—		—	—		(4,120)		—		—		(4,120)
Purchase and retirement of common stock through repurchase program		(620,200)	(1)		136,402	5,738		(23,950)		—		—		(18,213)
Stock-based compensation	Stock-based compensation	—	—		—	—		6,574		—		—		6,574		Stock-based compensation	—	—		7,838		—		—		7,838
Other comprehensive income		—	—		—	—		—		446		—		446
Other comprehensive loss																Other comprehensive loss	—	—		—		(1,896)		—		(1,896)
Net income	Net income	—	—		—	—		—		—		17,905		17,905		Net income	—	—		—		—		20,497		20,497
Balances, June 26, 2021		77,454,800	$	77	0	$	0	$	894,062	$	3,596	$	(128,188)	$	769,547
Balances, September 25, 2021																Balances, September 25, 2021	78,207,219	$	78	$	892,303	$	1,700	$	(107,691)	$	786,390

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands, except shares)

(Unaudited)


																		Shares of Common Stock	Common Stock		Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total
		Shares of Common Stock	Common Stock		Shares of Treasury Stock		Treasury Stock		Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total
		Six Months Ended June 27, 2020																Nine Months Ended September 26, 2020
Balances, December 28, 2019	Balances, December 28, 2019	75,764,990	$	76	0		$	0	$	885,821	$	(659)	$	(244,241)	$	640,997	Balances, December 28, 2019	75,764,990	$	76	$	885,821	$	(659)	$	(244,241)	$	640,997
Issuance of common stock under the Employee Stock Purchase Plan	Issuance of common stock under the Employee Stock Purchase Plan	311,591	—		—		—		4,066		—		—		4,066		Issuance of common stock under the Employee Stock Purchase Plan	485,566	—		7,875		—		—		7,875
Issuance of common stock pursuant to exercise of options	Issuance of common stock pursuant to exercise of options	105,769	1		—		—		868		—		—		869		Issuance of common stock pursuant to exercise of options	205,769	1		1,712		—		—		1,713
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	319,109	—		—		—		(3,800)		—		—		(3,800)		Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	927,169	1		(15,383)		—		—		(15,382)

Stock-based compensation	Stock-based compensation	—	—		—		—		11,114		—		—		11,114		Stock-based compensation	—	—		16,551		—		—		16,551
Other comprehensive income	Other comprehensive income	—	—		—		—		—		1,117		—		1,117		Other comprehensive income	—	—		—		3,138		—		3,138
Net income	Net income	—	—		—		—		—		—		36,359		36,359		Net income	—	—		—		—		59,250		59,250
Balances, September 26, 2020																	Balances, September 26, 2020	77,383,494	$	78	$	896,576	$	2,479	$	(184,991)	$	714,142

																		Three Months Ended September 26, 2020
Balances, June 27, 2020	Balances, June 27, 2020	76,501,459	$	77	0		$	0	$	898,069	$	458	$	(207,882)	$	690,722	Balances, June 27, 2020	76,501,459	$	77	$	898,069	$	458	$	(207,882)	$	690,722
		Three Months Ended June 27, 2020
Balances, March 28, 2020		76,158,251	$	77	$	0	$	0	$	895,600	$	(909)	$	(228,351)	$	666,417

Issuance of common stock under the Employee Stock Purchase Plan																	Issuance of common stock under the Employee Stock Purchase Plan	173,975	—		3,809		—		—		3,809
Issuance of common stock pursuant to exercise of options	Issuance of common stock pursuant to exercise of options	50,000	—		—		—		422		—		—		422		Issuance of common stock pursuant to exercise of options	100,000	—		844		—		—		844
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	293,208	—		—		—		(3,415)		—		—		(3,415)		Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	608,060	1		(11,583)		—		—		(11,582)

Stock-based compensation	Stock-based compensation	—	—		—		—		5,462		—		—		5,462		Stock-based compensation	—	—		5,437		—		—		5,437
Other comprehensive income	Other comprehensive income	—	—		—		—		—		1,367		—		1,367		Other comprehensive income	—	—		—		2,021		—		2,021
Net income	Net income	—	—		—		—		—		—		20,469		20,469		Net income	—	—		—		—		22,891		22,891
Balances, June 27, 2020		76,501,459	$	77	0		$	0	$	898,069	$	458	$	(207,882)	$	690,722
Balances, September 26, 2020																	Balances, September 26, 2020	77,383,494	$	78	$	896,576	$	2,479	$	(184,991)	$	714,142

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


		Six Months Ended					Nine Months Ended
		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Net income	Net income	$	37,530	$	36,359	Net income	$	58,027	$	59,250
Adjustments to reconcile net income to net cash provided by operating activities:	Adjustments to reconcile net income to net cash provided by operating activities:					Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	Depreciation	12,678		9,240		Depreciation	19,256		14,491
Amortization	Amortization	13,900		13,717		Amortization	16,362		20,249

Reduction in the carrying amount of right-of-use assets	Reduction in the carrying amount of right-of-use assets	3,652		2,419		Reduction in the carrying amount of right-of-use assets	5,412		4,294

Stock-based compensation expense	Stock-based compensation expense	13,665		11,265		Stock-based compensation expense	21,585		16,774

Provision for excess and obsolete inventories	Provision for excess and obsolete inventories	6,898		6,407		Provision for excess and obsolete inventories	11,621		9,763

Non-cash restructuring charges						Non-cash restructuring charges	1,592		—

Gain on contingent consideration	Gain on contingent consideration	(95)		(3,700)		Gain on contingent consideration	(95)		(3,771)

Other adjustments to reconcile net income to net cash provided by operating activities	Other adjustments to reconcile net income to net cash provided by operating activities	1,211		1,327		Other adjustments to reconcile net income to net cash provided by operating activities	1,627		(977)
Changes in assets and liabilities:	Changes in assets and liabilities:					Changes in assets and liabilities:
Accounts receivable	Accounts receivable	(1,194)		11,364		Accounts receivable	1,157		5,712
Inventories	Inventories	(20,388)		(11,089)		Inventories	(30,335)		(18,566)
Prepaid expenses and other current assets	Prepaid expenses and other current assets	3,179		(3,271)		Prepaid expenses and other current assets	3,631		(5,619)

Other assets	Other assets	(344)		248		Other assets	(333)		219
Accounts payable	Accounts payable	(2,028)		5,247		Accounts payable	1,488		18,054
Accrued liabilities	Accrued liabilities	(235)		1,529		Accrued liabilities	(6,951)		4,754

Other liabilities	Other liabilities	184		292		Other liabilities	47		272
Deferred revenues	Deferred revenues	1,522		3,855		Deferred revenues	2,000		3,806
Operating lease liabilities	Operating lease liabilities	(3,980)		(2,762)		Operating lease liabilities	(5,654)		(4,496)

Net cash provided by operating activities	Net cash provided by operating activities	66,155		82,447		Net cash provided by operating activities	100,437		124,209
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Acquisition of property, plant and equipment	Acquisition of property, plant and equipment	(31,322)		(36,743)		Acquisition of property, plant and equipment	(51,353)		(41,887)
Acquisition of business, net of cash acquired						Acquisition of business, net of cash acquired	—		(34,999)
Proceeds from sale of a subsidiary	Proceeds from sale of a subsidiary	0		82		Proceeds from sale of a subsidiary	—		82

Purchases of marketable securities	Purchases of marketable securities	(71,186)		(19,726)		Purchases of marketable securities	(114,898)		(29,721)
Proceeds from maturities and sales of marketable securities	Proceeds from maturities and sales of marketable securities	42,695		35,410		Proceeds from maturities and sales of marketable securities	71,275		50,330

Net cash used in investing activities	Net cash used in investing activities	(59,813)		(20,977)		Net cash used in investing activities	(94,976)		(56,195)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds from issuances of common stock	Proceeds from issuances of common stock	5,909		4,935		Proceeds from issuances of common stock	10,647		9,588
Purchase of common stock through stock repurchase program	Purchase of common stock through stock repurchase program	(23,951)		0		Purchase of common stock through stock repurchase program	(23,951)		—
Tax withholdings related to net share settlements of equity awards	Tax withholdings related to net share settlements of equity awards	(5,261)		(3,800)		Tax withholdings related to net share settlements of equity awards	(12,643)		(15,382)
Payment of contingent consideration	Payment of contingent consideration	(3,873)		0		Payment of contingent consideration	(3,873)		—
Proceeds from term loan debt		0		18,000
Proceeds from term loan						Proceeds from term loan	—		18,000
Principal repayments on term loans	Principal repayments on term loans	(4,740)		(26,322)		Principal repayments on term loans	(7,049)		(41,098)
Payment of term loan debt issuance costs	Payment of term loan debt issuance costs	0		(78)		Payment of term loan debt issuance costs	—		(78)
Net cash used in financing activities	Net cash used in financing activities	(31,916)		(7,265)		Net cash used in financing activities	(36,869)		(28,970)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,558)		583		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2,216)		1,262
Net increase (decrease) in cash, cash equivalents and restricted cash	Net increase (decrease) in cash, cash equivalents and restricted cash	(27,132)		54,788		Net increase (decrease) in cash, cash equivalents and restricted cash	(33,624)		40,306
Cash, cash equivalents and restricted cash, beginning of period	Cash, cash equivalents and restricted cash, beginning of period	191,098		147,937		Cash, cash equivalents and restricted cash, beginning of period	191,098		147,937
Cash, cash equivalents and restricted cash, end of period	Cash, cash equivalents and restricted cash, end of period	$	163,966	$	202,725	Cash, cash equivalents and restricted cash, end of period	$	157,474	$	188,243

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


		Six Months Ended					Nine Months Ended
		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020
Non-cash investing and financing activities:	Non-cash investing and financing activities:					Non-cash investing and financing activities:

Increase (decrease) in accounts payable and accrued liabilities related to property, plant and equipment purchases		$	2,906	$	(2,274)
Increase in accounts payable and accrued liabilities related to property, plant and equipment purchases						Increase in accounts payable and accrued liabilities related to property, plant and equipment purchases	$	4,684	$	3,041
Increase in accrued liabilities related to tax withholdings related to net share settlements of equity awards						Increase in accrued liabilities related to tax withholdings related to net share settlements of equity awards	6,952		—
Operating lease, right-of-use assets obtained in exchange for lease obligations	Operating lease, right-of-use assets obtained in exchange for lease obligations	11,629		428		Operating lease, right-of-use assets obtained in exchange for lease obligations	11,699		1,549

Supplemental disclosure of cash flow information:	Supplemental disclosure of cash flow information:					Supplemental disclosure of cash flow information:
Cash paid for income taxes, net	Cash paid for income taxes, net	$	4,559	$	4,133	Cash paid for income taxes, net	$	6,795	$	7,475
Cash paid for interest	Cash paid for interest	339		473		Cash paid for interest	496		683
Operating cash outflows from operating leases						Operating cash outflows from operating leases	6,420		5,566

Reconciliation of cash, cash equivalents and restricted cash:	Reconciliation of cash, cash equivalents and restricted cash:					Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	Cash and cash equivalents	$	160,273	$	199,926	Cash and cash equivalents	$	153,781	$	185,368
Restricted cash, current	Restricted cash, current	1,857		1,424		Restricted cash, current	2,019		1,477
Restricted cash, non-current	Restricted cash, non-current	1,836		1,375		Restricted cash, non-current	1,674		1,398
Total cash, cash equivalents and restricted cash	Total cash, cash equivalents and restricted cash	$	163,966	$	202,725	Total cash, cash equivalents and restricted cash	$	157,474	$	188,243

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 — Basis of Presentation and New Accounting Pronouncements

Basis of Presentation

The accompanying condensed consolidated financial information of FormFactor, Inc. is unaudited and has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). However, such information reflects all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in our 2020 Annual Report on Form 10-K filed with the SEC on February 22, 2021. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.

Fiscal Year

We operate on a 52/53 week fiscal year, whereby the fiscal year ends on the last Saturday of December. Fiscal 2021 and 2020 each contain 52 weeks and the ~~six~~nine months ended ~~June 26,~~September 25, 2021 and ~~June 27,~~September 26, 2020 each contained 2639 weeks. Fiscal 2021 will end on December 25, 2021.

Significant Accounting Policies

Our significant accounting policies have not changed during the ~~six~~nine months ended ~~June 26,~~September 25, 2021 from those disclosed in our Annual Report on Form 10-K for the year ended December 26, 2020.

New Accounting Pronouncements

ASU 2019-12

In December 2019, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, “Income Taxes (Topic 740),” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. We adopted ASU 2019-12 on a prospective basis on December 27, 2020, the first day of fiscal 2021. The adoption did not have a material effect on our consolidated financial position, results of operations or cash flows.

ASU 2020-04

In March 2020, the FASB issued ASU 2020-04, “Referenced Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. ASU 2020-04 became effective upon issuance and may be applied prospectively to contract modifications made on or before December 31, 2022. ASU 2021-01 became effective upon issuance and may be applied on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively for contract modifications made on or before December 31, 2022. The Company has not yet applied the relief afforded by these standard amendments and is currently assessing contracts that will require modification due to reference rate reform to which these standard amendments may be applied.

Note 2 — Concentration of Credit and Other Risks

Each of the following customers accounted for 10% or more of our revenues for the periods indicated:


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		June 26, 2021		June 27, 2020		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Intel Corporation	Intel Corporation	16.2	%	36.1	%	22.1	%	36.2	%	Intel Corporation	20.8	%	25.6	%	21.7	%	32.4	%
Samsung Electronics., LTD.	Samsung Electronics., LTD.	14.7	%	*		*		*		Samsung Electronics., LTD.	12.9	%	10.6	%	10.5	%	*
Taiwan Semiconductor Manufacturing Co., LTD.	Taiwan Semiconductor Manufacturing Co., LTD.	11.0	%	*		11.2	%	*		Taiwan Semiconductor Manufacturing Co., LTD.	*		10.6	%	*		*
Micron Technology, Inc.										Micron Technology, Inc.	*		10.1	%	*		*

											33.7	%	56.9	%	32.2	%	32.4	%
		41.9	%	36.1	%	33.3	%	36.2	%

*Represents less than 10% of total revenues.

At ~~June 26,~~September 25, 2021, one customer accounted for ~~20.6%~~19.3% of gross accounts receivable. At December 26, 2020, two customers accounted for 15.3% and 13.7% of gross accounts receivable, respectively.

Note 3 — Inventories, net

Inventories are stated at the lower of cost (principally standard cost, which approximates actual cost on a first in, first out basis) or net realizable value.

Inventories, net, consisted of the following (in thousands):


		June 26, 2021		December 26, 2020			September 25, 2021		December 26, 2020
Raw materials	Raw materials	$	56,138	$	48,122	Raw materials	$	55,352	$	48,122
Work-in-progress	Work-in-progress	35,911		30,806		Work-in-progress	41,638		30,806
Finished goods	Finished goods	19,841		20,301		Finished goods	18,114		20,301
		$	111,890	$	99,229		$	115,104	$	99,229

Note 4 — ~~Acquisition~~Acquisitions

High Precision Devices, Inc. Acquisition

On October 19, 2020, we acquired ~~100% of the shares of~~ HPD for total consideration of $16.9 million, net of cash acquired of $1.7 million, which included an adjustment for changes in working capital. This acquisition brings highly specialized skills and know-how to address the unique test challenges within the emerging quantum computing, superconducting computing, and ultra-sensitive sensor markets which operate at temperatures as low as 30 millikelvin.

The acquisition was accounted for using the acquisition method of accounting, with FormFactor treated as the acquirer. The acquired assets and liabilities of HPD were recorded at their respective fair values including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets.

Our Condensed Consolidated Statements of Income include the financial results of HPD subsequent to the acquisition date of October 19, 2020. Revenue in fiscal 2020 related to HPD subsequent to the acquisition date that was included in our Condensed Consolidated Statements of Income was not material.

accounting. The acquisition price was allocated to the tangible and identified intangible assets acquired and liabilities assumed as of the closing date of the acquisition based upon their respective fair ~~values.~~values, including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets. The fair values assigned to the assets acquired and liabilities assumed were based on management’s assumptions as of the ~~reporting~~acquisition date.

~~We estimated the acquisition price and the allocation of fair value to assets acquired and liabilities assumed as of the acquisition date, October 19, 2020.~~ We subsequently made certain immaterial adjustments within the measurement period to the ~~preliminary~~ acquisition price ~~allocation.~~allocation as a result of finalization of our valuation of identifiable assets and liabilities. See Note 5, Goodwill and Intangible Assets, for the changes ~~in identified intangible values~~

in identified intangible values and goodwill. ~~Our purchase accounting remains open at June 26, 2021, subject to finalization~~The final allocation of ~~certain deferred tax items. The estimated fair value of~~the assets acquired, including goodwill and intangibles, and liabilities assumed for the purchase is as follows (in thousands):


	Amount
Cash and cash equivalents	$	1,680
Accounts receivable	1,017
Inventories	3,047
Property, plant and equipment	669
Operating lease, right of use assets	2,554
Prepaid expenses and other current assets	~~599~~916
Tangible assets acquired	~~9,566~~9,883
Deferred revenue	(2,529)
Accounts payable and accrued liabilities	(1,268)
Operating lease liabilities	(2,554)
Deferred tax liabilities	~~(2,840)~~(2,400)
Total tangible assets acquired and liabilities assumed	~~375~~1,132
Intangible assets	11,520
Goodwill	~~6,665~~5,908
Net Assets Acquired	$	18,560

The intangible assets as of the ~~closing date of the~~ acquisition included (in thousands):


	Amount		Weighted Average Useful Life (in years)
Developed technologies	$	7,500	10.0
Customer relationships	3,600		5.0
Order backlog	200		0.5
Trade names	220		5.0
Total intangible assets	$	11,520	8.2

The fair value of the intangible assets acquired in connection with the acquisition was determined using either the income, market or replacement cost methodologies. The intangible assets are being amortized over periods which reflect the pattern in which economic benefits of the assets are expected to be realized.

~~Identifiable Intangible Assets~~

~~Valuation of intangible assets involves multiple assumptions. The key assumptions are described below.~~

Developed technology acquired primarily consists of existing technology related to cryogenic probe stations, Adiabatic Demagnetization Refrigerator (“ADR”), and continuous ADR cryostats and similar tools, and technology related to other cryogenic applications. We valued the developed technology using the multi-period excess earnings method under the income approach. Using this approach, the estimated fair values were calculated using expected future cash flows from specific products discounted to their net present values at an appropriate risk-adjusted rate of return.

The value of customer relationships represents the fair value of future projected revenues that will be derived from the sale of products to HPD's existing customers. We valued customer relationships using the incremental cash flow method. This method estimates value based on the incremental cash flow afforded by having the customers relationships in place on the acquisition date versus having no relationships in place and needing to replicate or replace those relationships. The incremental cash flows are then discounted to a present value to arrive at an estimate of fair value for this asset class.

Order backlog represents the value of future sales under existing contracts as of the acquisition date. Expected cash flow from order backlog was valued on a discounted direct cash flow basis, net of returns on contributory assets such as working capital, property and equipment, trade name and assembled workforce.

The identified trade names intangibles relate to the estimated fair value of future cash flows related to the HPD brand. We valued trade names by applying the relief-from-royalty method under the income approach. This method is based on the application of a royalty rate to forecasted revenue under the trade name.

~~Goodwill~~

The excess of purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the amount of goodwill resulting from the acquisition. We believe the factors that contributed to goodwill include synergies that are specific to our consolidated business, such as cost savings and operational efficiencies, and the acquisition of a talented workforce that expands our expertise in business development and commercializing semiconductor test products, none of which qualify for recognition as a separate intangible asset. We do not expect any portion of this goodwill to be deductible for tax purposes. The goodwill attributable to the acquisition was recorded as a non-current asset and is not amortized, but is subject to an annual review for impairment.

~~The goodwill arising from the acquisition was allocated to the HPD reporting unit within the Systems reportable segment.~~

~~We have not presented unaudited combined pro forma financial information as the HPD acquisition was not significant to our consolidated results of operations and financial position.~~

Baldwin Park Acquisition

On July 30, 2020, we acquired the probe card assets of Advantest Corporation for total ~~cash~~ consideration of $35.0 million. This acquisition brings important enabling technologies and capabilities for designing and manufacturing advanced probe cards, and adds a complementary 3D-NAND Flash probe-card product that is qualified and in production at one of the world's leading NAND Flash manufacturers.

The acquisition was accounted for using the acquisition method of ~~accounting, with FormFactor treated as~~accounting. The acquisition price was allocated to the ~~acquirer. The~~tangible and identified intangible assets acquired ~~assets~~ and liabilities assumed as of ~~Baldwin Park were recorded at~~the closing date of the acquisition based upon their respective fair values including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets.

Our Condensed Consolidated Statements of Income include the financial results of Baldwin Park subsequent to the acquisition date of July 30, 2020. Revenue related to Baldwin Park since the acquisition date that was included in our Condensed Consolidated Statements of Income for fiscal 2020 was not material.

~~We estimated the acquisition price and the allocation of~~ The fair ~~value~~values assigned to assets acquired and liabilities assumed were based on management's assumptions as of the acquisition ~~date, July 30, 2020.~~date. We subsequently made certain immaterial adjustments within the measurement period to the acquisition price allocation as a result of finalization of our valuation of identifiable assets and liabilities. See Note 5, Goodwill and Intangible Assets, for the changes in identified intangible values and goodwill. The final

allocation of the assets acquired, including goodwill and intangibles, and liabilities assumed for the purchase as follows (in thousands):


	Amount
Accounts receivable	$	4,365
Inventories	2,727
Property, plant and equipment	9,053
Operating lease, right of use assets	519
Prepaid expenses and other current assets	56
Tangible assets acquired	16,720
Accounts payable and accrued liabilities	(743)
Operating lease liabilities	(519)
Total tangible assets acquired and liabilities assumed	15,458
Intangible assets	13,600
Goodwill	5,942
Net assets acquired	$	35,000

The intangible assets as of ~~July 30, 2020~~the acquisition date included (in thousands):


	Amount		Weighted Average Useful Life (in years)
Developed technologies	$	8,800	10.0
Customer relationships	4,400		3.0
In-process research and development	400		N/A
Total intangible assets	$	13,600	7.7

Indications of fair value of the intangible assets acquired in connection with the acquisition were determined using either the income, market or replacement cost methodologies. The intangible assets are being amortized over periods which reflect the pattern in which economic benefits of the assets are expected to be realized.

~~Identifiable Intangible Assets~~

~~Valuation of intangible assets involves multiple assumptions. The key assumptions are described below.~~

Developed technology acquired consists of existing technology related to 3D NAND Flash probe cards and the value expected to be derived from interconnect technology. We valued the developed technology related to 3D NAND Flash using the multi-period excess earnings method under the income approach. Using this approach, the estimated fair values were calculated using expected future cash flows from specific products discounted to their net present values at an appropriate risk-adjusted rate of return. We valued the interconnect developed technology asset using the incremental cash flow method. This method estimates value based on the incremental cash flow afforded by having the interconnect capability in place on the acquisition date versus having no capability in place and needing to replicate or replace that capability. The incremental cash flows are then discounted to a present value to arrive at an estimate of fair value for this asset class.

The value of customer relationships represents the fair value of future projected revenues that will be derived from the sale of products to Baldwin Park's existing customers. We valued customer relationships using the incremental cash flow method. This method estimates value based on the incremental cash flow afforded by having the customers relationships in place on the acquisition date versus having no relationships in place and needing to replicate or replace those relationships. The incremental cash flows are then discounted to a present value to arrive at an estimate of fair value for this asset class.

In-process research and development (“IPR&D”) acquired primarily consists of research and development projects that were in process at the time of acquisition related to technologies used in DRAM probe cards. Once these projects are complete they will be amortized over their useful life. We valued the IPR&D using the multi-period excess earnings method under the income approach. Using this approach, the estimated fair values were calculated using expected future cash flows from specific products discounted to their net present values at an appropriate risk-adjusted rate of return.

~~Goodwill~~

The excess of purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the amount of goodwill resulting from the acquisition. We believe the factors that contributed to goodwill include synergies that are specific to our consolidated business, such as cost savings and operational efficiencies, and the acquisition of a talented workforce that expands our expertise in business development, none of which qualify for recognition as a separate intangible asset. We expect this goodwill to be deductible for tax purposes. The goodwill attributable to the acquisition was recorded as a non-current asset and is not amortized, but is subject to an annual review for impairment.

~~The goodwill arising from the acquisition was allocated to the Probe Cards reporting unit within the Probe Cards reportable segment.~~

~~We have not presented unaudited combined pro forma financial information as the Baldwin Park acquisition was not significant to our consolidated results of operations and financial position.~~

Note 5 — Goodwill and Intangible Assets

Goodwill by reportable segment was as follows (in thousands):


		Probe Cards		Systems		Total			Probe Cards		Systems		Total
Goodwill, gross, as of December 28, 2019	Goodwill, gross, as of December 28, 2019	$	172,482	$	26,714	$	199,196	Goodwill, gross, as of December 28, 2019	$	172,482	$	26,714	$	199,196
Addition - FRT GmbH Acquisition	Addition - FRT GmbH Acquisition	0		975		975		Addition - FRT GmbH Acquisition	—		975		975
Addition - Baldwin Park Acquisition	Addition - Baldwin Park Acquisition	5,590		0		5,590		Addition - Baldwin Park Acquisition	5,590		—		5,590
Addition - HPD Acquisition	Addition - HPD Acquisition	0		4,654		4,654		Addition - HPD Acquisition	—		4,654		4,654
Foreign currency translation	Foreign currency translation	0		2,346		2,346		Foreign currency translation	—		2,346		2,346
Goodwill, gross, as of December 26, 2020	Goodwill, gross, as of December 26, 2020	178,072		34,689		212,761		Goodwill, gross, as of December 26, 2020	178,072		34,689		212,761
Addition - Baldwin Park Acquisition	Addition - Baldwin Park Acquisition	352		0		352		Addition - Baldwin Park Acquisition	352		—		352
Addition - HPD Acquisition	Addition - HPD Acquisition	0		2,011		2,011		Addition - HPD Acquisition	—		1,254		1,254
Foreign currency translation	Foreign currency translation	0		(576)		(576)		Foreign currency translation	—		(1,074)		(1,074)
Goodwill, gross, as of July 26, 2021		$	178,424	$	36,124	$	214,548
Goodwill, gross, as of September 25, 2021								Goodwill, gross, as of September 25, 2021	$	178,424	$	34,869	$	213,293

We have 0tnot recorded goodwill impairments for the ~~six~~nine months ended ~~June 26,~~September 25, 2021.

Intangible assets were as follows (in thousands):


		June 26, 2021						December 26, 2020							September 25, 2021						December 26, 2020
Intangible Assets	Intangible Assets	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net		Intangible Assets	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Developed technologies	Developed technologies	$	173,627	$	147,968	$	25,659	$	176,265	$	137,754	$	38,511	Developed technologies	$	173,160	$	148,518	$	24,642	$	176,265	$	137,754	$	38,511
Customer relationships	Customer relationships	51,641		36,437		15,204		52,488		33,378		19,110		Customer relationships	51,514		37,885		13,629		52,488		33,378		19,110
Trade names	Trade names	8,140		7,520		620		8,162		7,363		799		Trade names	8,110		7,586		524		8,162		7,363		799
Order backlog	Order backlog	1,990		1,960		30		2,227		1,900		327		Order backlog	1,958		1,958		—		2,227		1,900		327
In-process research and development	In-process research and development	400		0		400		400		0		400		In-process research and development	400		—		400		400		—		400
		$	235,798	$	193,885	$	41,913	$	239,542	$	180,395	$	59,147		$	235,142	$	195,947	$	39,195	$	239,542	$	180,395	$	59,147

Amortization expense was included in our Condensed Consolidated Statements of Income as follows (in thousands):


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		June 26, 2021		June 27, 2020		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Cost of revenues	Cost of revenues	$	5,505	$	4,926	$	10,595	$	10,676	Cost of revenues	$	858	$	4,985	$	11,453	$	15,661
Selling, general and administrative	Selling, general and administrative	1,590		1,528		3,305		3,041		Selling, general and administrative	1,604		1,547		4,909		4,588
		$	7,095	$	6,454	$	13,900	$	13,717		$	2,462	$	6,532	$	16,362	$	20,249

The estimated future amortization of definite-lived intangible assets, excluding in-process research and development, is as follows (in thousands):


Fiscal Year	Fiscal Year	Amount		Fiscal Year	Amount
Remainder of 2021	Remainder of 2021	$	4,885	Remainder of 2021	$	2,401
2022	2022	9,647		2022	9,592
2023	2023	7,271		2023	7,224
2024	2024	4,652		2024	4,611
2025	2025	4,389		2025	4,351
Thereafter	Thereafter	10,669		Thereafter	10,616
		$	41,513		$	38,795

Note 6 — Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):


		June 26, 2021		December 26, 2020			September 25, 2021		December 26, 2020
Accrued compensation and benefits	Accrued compensation and benefits	$	31,210	$	33,110	Accrued compensation and benefits	$	37,913	$	33,110
Accrued income and other taxes	Accrued income and other taxes	6,049		6,976		Accrued income and other taxes	5,466		6,976
Accrued warranty	Accrued warranty	4,258		3,918		Accrued warranty	2,803		3,918
Employee stock purchase plan contributions withheld	Employee stock purchase plan contributions withheld	4,768		4,240		Employee stock purchase plan contributions withheld	1,924		4,240
Accrued contingent consideration	Accrued contingent consideration	0		4,012		Accrued contingent consideration	—		4,012
Accrued restructuring charges						Accrued restructuring charges	3,675		—
Other accrued expenses	Other accrued expenses	5,202		3,086		Other accrued expenses	2,844		3,086
		$	51,487	$	55,342		$	54,625	$	55,342

Note 7— Restructuring Charges

On September 25, 2021, we adopted restructuring plans to improve our business effectiveness and streamline our operations by consolidating certain manufacturing facilities for both the Probe Cards segment and the Systems segment. This includes plans to consolidate or relocate certain leased locations in the United States to other locations in the United States, Germany and Asia. As a result of these changes to certain work locations, we have incurred, and expect to incur, personnel related costs to sever, relocate, or retain select employees. Additionally, we are undertaking actions to adjust capacity for certain product offerings. As a result of these adjustments, contract termination costs include charges to satisfy contract obligations. The liability was recognized using our best estimate and it is reasonably possible that the final amount will differ from the amount estimated in the near term. We expect the actions defined under these plans will be largely completed by the end of December 2022, except facilities charges which may extend beyond that time.

This plan is expected to result in FormFactor recording restructuring and other charges in the aggregate amount of approximately $8.0 million to $10.5 million, estimated to be comprised primarily of $1.0 million to $2.0 million of severance and employee-related costs, $3.5 million to 4.5 million in contract and lease termination costs, $1.0 million to $1.5 million in inventory impairments, and $2.0 million to $2.5 million of cost related to impairment of leasehold improvements, facility exits, and other costs. Approximately $5.0 million to $6.0 million and $3.0 million to $4.5 million is expected within the Probe Cards segment and Systems segment, respectively.

Restructuring charges by reportable segment included in our Condensed Consolidated Statements of Income were as follows (in thousands):


	Three Months Ended						Nine Months Ended
	September 25, 2021						September 25, 2021
	Probe Cards		Systems		Total		Probe Cards		Systems		Total
Cost of revenues	$	4,070	$	252	$	4,322	$	4,070	$	420	$	4,490
Research and development	—		289		289		—		694		694
Selling, general and administrative	—		22		22		—		83		83
	$	4,070	$	563	$	4,633	$	4,070	$	1,197	$	5,267

Changes to the restructuring accrual in the nine months ended September 25, 2021 were as follows (in thousands):


	Employee Severance and Benefits		Inventory Impairments		Property and Equipment Impairments		Contract Termination Costs		Total
December 26, 2020	$	—	$	—	$	—	$	—	$	—
Restructuring charges	875		1,322		270		2,800		5,267


Non-cash settlement	—		(1,322)		(270)		—		(1,592)
September 25, 2021	$	875	$	—	$	—	$	2,800	$	3,675

Note 78 — Fair Value and Derivative Instruments

Whenever possible, the fair values of our financial assets and liabilities are determined using quoted market prices of identical securities or quoted market prices of similar securities from active markets. The three levels of inputs that may be used to measure fair value are as follows:

•Level 1 valuations are obtained from real-time quotes for transactions in active exchange markets involving identical securities;

•Level 2 valuations utilize significant observable inputs, such as quoted prices for similar assets or liabilities, quoted prices near the reporting date in markets that are less active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

•Level 3 valuations utilize unobservable inputs to the valuation methodology and include our own data about assumptions market participants would use in pricing the asset or liability based on the best information available under the circumstances.

We did not have any transfers of assets or liabilities measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 during the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021 or the year ended December 26, 2020.

The carrying values of Cash, Accounts receivable, net, Restricted cash, Prepaid expenses and other current assets, Accounts payable, Accrued liabilities, and term loans, net of unamortized issuance costs, approximate fair value due to their short maturities.

No changes were made to our valuation techniques during the first ~~six~~nine months of fiscal 2021.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):


June 26, 2021		Level 1		Level 2		Level 3		Total
September 25, 2021										September 25, 2021	Level 1		Level 2		Level 3		Total
Assets:	Assets:									Assets:
Cash equivalents:	Cash equivalents:									Cash equivalents:
Money market funds	Money market funds	$	25,917	$	0	$	0	$	25,917	Money market funds	$	12,621	$	—	$	—	$	12,621

U.S. treasuries										U.S. treasuries	5,300		—		—		5,300
											17,921		—		—		17,921
Marketable securities:	Marketable securities:									Marketable securities:
U.S. treasuries	U.S. treasuries	27,112		0		0		27,112		U.S. treasuries	37,135		—		—		37,135
Certificates of deposit	Certificates of deposit	0		1,207		0		1,207		Certificates of deposit	—		723		—		723
U.S. agency securities	U.S. agency securities	0		575		0		575		U.S. agency securities	—		575		—		575
Corporate bonds	Corporate bonds	0		28,893		0		28,893		Corporate bonds	—		27,336		—		27,336
Commercial paper	Commercial paper	0		38,175		0		38,175		Commercial paper	—		45,129		—		45,129
		27,112		68,850		0		95,962			37,135		73,763		—		110,898
Foreign exchange derivative contracts (Designated)		0		152		0		152

Interest rate swap derivative contracts	Interest rate swap derivative contracts	0		571		0		571		Interest rate swap derivative contracts	—		548		—		548
Total assets	Total assets	$	53,029	$	69,573	$	0	$	122,602	Total assets	$	55,056	$	74,311	$	—	$	129,367
Liabilities:	Liabilities:									Liabilities:
Foreign exchange derivative contracts (Designated)	Foreign exchange derivative contracts (Designated)	$	0	$	(53)	$	0	$	(53)	Foreign exchange derivative contracts (Designated)	$	—	$	(258)	$	—	$	(258)
Interest rate swap derivative contracts	Interest rate swap derivative contracts	0		(103)		0		(103)		Interest rate swap derivative contracts	—		(100)		—		(100)

Total liabilities	Total liabilities	$	0	$	(156)	$	0	$	(156)	Total liabilities	$	—	$	(358)	$	—	$	(358)


December 26, 2020	December 26, 2020	Level 1		Level 2		Level 3		Total		December 26, 2020	Level 1		Level 2		Level 3		Total
Assets:	Assets:									Assets:
Cash equivalents:	Cash equivalents:									Cash equivalents:
Money market funds	Money market funds	$	43,019	$	0	$	0	$	43,019	Money market funds	$	43,019	$	—	$	—	$	43,019

Marketable securities:	Marketable securities:									Marketable securities:
U.S. treasuries	U.S. treasuries	40,726		0		0		40,726		U.S. treasuries	40,726		—		—		40,726
Certificates of deposit	Certificates of deposit	0		2,179		0		2,179		Certificates of deposit	—		2,179		—		2,179
U.S. agency securities	U.S. agency securities	0		575		0		575		U.S. agency securities	—		575		—		575
Corporate bonds	Corporate bonds	0		24,330		0		24,330		Corporate bonds	—		24,330		—		24,330

		40,726		27,084		0		67,810			40,726		27,084		—		67,810
Foreign exchange derivative contracts	Foreign exchange derivative contracts	0		1,057		0		1,057		Foreign exchange derivative contracts	—		1,057		—		1,057
Interest rate swap derivative contracts	Interest rate swap derivative contracts	0		57		0		57		Interest rate swap derivative contracts	—		57		—		57
Total assets	Total assets	$	83,745	$	28,198	$	0	$	111,943	Total assets	$	83,745	$	28,198	$	—	$	111,943
Liabilities:	Liabilities:									Liabilities:

Interest rate swap derivative contracts	Interest rate swap derivative contracts	$	0	$	(87)	$	0	$	(87)	Interest rate swap derivative contracts	$	—	$	(87)	$	—	$	(87)
Contingent consideration	Contingent consideration	0		0		(4,012)		(4,012)		Contingent consideration	—		—		(4,012)		(4,012)
Total liabilities	Total liabilities	$	0	$	(87)	$	(4,012)	$	(4,099)	Total liabilities	$	—	$	(87)	$	(4,012)	$	(4,099)

Cash Equivalents

The fair value of our cash equivalents is determined based on quoted market prices for similar or identical securities.

Marketable Securities

We classify our marketable securities as available-for-sale and value them utilizing a market approach. Our investments are

priced by pricing vendors who provide observable inputs for their pricing without applying significant judgment. Broker pricing is used mainly when a quoted price is not available, the investment is not priced by our pricing vendors or when a broker price is more reflective of fair value. Our broker-priced investments are categorized as Level 2 investments because fair value is based on similar assets without applying significant judgments. In addition, all investments have a sufficient trading volume to demonstrate that the fair value is appropriate.

Unrealized gains and losses were immaterial and were recorded as a component of Accumulated other comprehensive income

in our Condensed Consolidated Balance Sheets. We did not have any other-than-temporary unrealized gains or losses at either period end included in these financial statements.

Contingent Consideration

Contingent consideration, arising from the acquisition of FRT GmbH, was a cash amount equal to 1.5x EBIT as defined in the purchase agreement, up to a maximum of €10.3 million, payable subject to the performance of the acquired business in calendar 2020. We estimated the fair value of contingent consideration using a probability weighted approach. Key assumptions in determining the fair value of contingent consideration included estimating EBIT levels that we believed as of the acquisition date were likely to be achieved during the performance period and discounting at an appropriate discount rate. We settled our contingent consideration in the ~~current~~second quarter of fiscal 2021 for $3.9 million, resulting in a $0.1 million credit to Selling, general and administrative expense with the remaining change from December 26, 2020 resulting from foreign currency translation.

Interest Rate Swaps

The fair value of our interest rate swap contracts is determined at the end of each reporting period based on valuation models that use interest rate yield curves as inputs. For accounting purposes, our interest rate swap contracts qualify for, and are designated as, cash flow hedges. The cash flows associated with the interest rate swaps are reported in Net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows and the fair value of the interest rate swap contracts are recorded within Accrued liabilities and Other ~~liabilities~~assets in our Condensed Consolidated Balance Sheets.

~~The impact of the interest rate swaps on our Condensed Consolidated Statements of Income was as follows (in thousands):~~

Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion) Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)
Three Months Ended June 26, 2021 $ (203) Interest expense $ (39) Interest expense $ —
Three Months Ended June 27, 2020 $ (174) Interest expense $ (10) Interest expense $ —
Six Months Ended June 26, 2021 $ 421 Interest expense $ (77) Interest expense $ —
Six Months Ended June 27, 2020 $ (270) Interest expense $ 12 Interest expense $ —

Foreign Exchange Derivative Contracts

We operate and sell our products in various global markets. As a result, we are exposed to changes in foreign currency exchange rates. We utilize foreign currency forward contracts to hedge against future movements in foreign exchange rates that affect certain existing foreign currency denominated assets and liabilities and forecasted foreign currency revenue and expense transactions. Under this program, our strategy is to have increases or decreases in our foreign currency exposures mitigated by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with foreign currency transaction gains or losses.

We do not use derivative financial instruments for speculative or trading purposes. For accounting purposes, certain of our foreign currency forward contracts are not designated as hedging instruments and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded within Other expense, net in our Condensed Consolidated Statement of Income for both realized and unrealized gains and losses. Certain of our foreign currency forward contracts are designated as cash flow hedges, and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded as a component of Accumulated other comprehensive income and reclassified into earnings in the same period in which the hedged transaction affects earnings, and in the same line item on the Condensed Consolidated Statements of Income as the impact of the hedge transaction.

The fair value of our foreign exchange derivative contracts was determined based on current foreign currency exchange rates and forward points. All of our foreign exchange derivative contracts outstanding at ~~June 26,~~September 25, 2021 will mature by the ~~second~~third quarter of fiscal 2022.

1817

The following table provides information about our foreign currency forward contracts outstanding as of ~~June 26,~~September 25, 2021 (in thousands):
Currency Contract Position Contract Amount
(Local Currency) Contract Amount
(U.S. Dollars)
Euro Dollar Buy (12,678) $ (15,124)
Japanese Yen Sell 1,802,229 16,251
Korean Won Buy (3,050,367) (2,703)
Total USD notional amount of outstanding foreign exchange contracts $ (1,576)


Currency	Contract Position	Contract Amount (Local Currency)	Contract Amount (U.S. Dollars)
Euro Dollar	Buy	(11,900)	$	(14,245)
Euro Dollar	Sell	2,520	2,953
Japanese Yen	Sell	1,992,865	17,994
Korean Won	Buy	(2,513,139)	(2,138)
Taiwan Dollar	Sell	7,440	269

Total USD notional amount of outstanding foreign exchange contracts			$	4,833

Our foreign currency contracts are classified within Level 2 of the fair value hierarchy as they are valued using pricing models that utilize observable market inputs.

~~The impact of foreign exchange derivative contracts not designated as cash flow hedges on our Condensed Consolidated Statements of Income was as follows (in thousands):~~

Amount of Gain (Loss) Recognized on Derivatives
Three Months Ended Six Months Ended
Derivatives Not Designated as Hedging Instruments Location of Gain (Loss) Recognized on Derivatives June 26,
2021 June 27,
2020 June 26,
2021 June 27,
2020
Foreign exchange forward contracts Other expense, net $ (69) $ 234 $ 1,220 $ 349

~~The impact of foreign exchange derivative contracts designated as cash flow hedges on our Condensed Consolidated Statements of Income was as follows (in thousands):~~

Amount of Gain (Loss) Recognized in Accumulated OCI on Derivative Location of Gain (Loss) Reclassified from Accumulated OCI into Income Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Three Months Ended June 26, 2021 $ 278 Cost of revenues $ 134
Research and development 16
Selling, general and administrative 52
$ 202
Three Months Ended June 27, 2020 $ 52 Cost of revenues $ (139)
Research and development (17)
Selling, general and administrative (35)
$ (191)
Six Months Ended June 26, 2021 $ (248) Cost of revenues $ 384
Research and development 46
Selling, general and administrative 134
$ 564
Six Months Ended June 27, 2020 $ (126) Cost of revenues $ (258)
Research and development (35)
Selling, general and administrative (79)
$ (372)

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

We measure and report our non-financial assets such as Property, plant and equipment, Goodwill and Intangible assets at fair value on a non-recurring basis if we determine these assets to be impaired or in the period when we make a business acquisition. Other than as discussed in Note 4, Acquisition, and Note 7, Restructuring, there were 0no assets or liabilities measured at fair value on a nonrecurring basis during the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021 or ~~June 27,~~September 26, 2020.

Note 89 — Warranty

We offer warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based upon historical experience and our estimate of the level of future costs. While we engage in product quality programs and processes, our warranty obligation is affected by product failure rates, material usage and service delivery costs. We continuously monitor product returns for warranty and maintain a reserve for the related expenses based upon our historical experience and any specifically identified failures. As we sell new products to our customers, we must exercise considerable judgment in estimating the expected failure rates. This estimating process is based on historical experience of similar products, as well as various other assumptions that we believe to be reasonable under the circumstances. We provide for the estimated cost of product warranties at the time revenue is recognized as a component of Cost of revenues in our Condensed Consolidated Statement of Income.

Changes in our warranty liability were as follows (in thousands):


		Six Months Ended					Nine Months Ended
		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020
Balance at beginning of period	Balance at beginning of period	$	3,918	$	1,942	Balance at beginning of period	$	3,918	$	1,942
Accruals	Accruals	3,472		2,116		Accruals	4,688		2,771
Settlements	Settlements	(3,132)		(1,997)		Settlements	(5,803)		(2,838)
Balance at end of period	Balance at end of period	$	4,258	$	2,061	Balance at end of period	$	2,803	$	1,875

Note 910 — Property, Plant and Equipment, net

Property, plant and equipment, net consisted of the following (in thousands):


		June 26, 2021		December 26, 2020			September 25, 2021		December 26, 2020
Land	Land	$	4,751	$	4,751	Land	$	4,751	$	4,751
Machinery and equipment	Machinery and equipment	239,322		226,185		Machinery and equipment	243,729		226,185
Computer equipment and software	Computer equipment and software	44,273		36,361		Computer equipment and software	44,241		36,361
Furniture and fixtures	Furniture and fixtures	6,924		6,894		Furniture and fixtures	6,930		6,894
Leasehold improvements	Leasehold improvements	81,421		79,144		Leasehold improvements	82,072		79,144
Sub-total	Sub-total	376,691		353,335		Sub-total	381,723		353,335
Less: Accumulated depreciation and amortization	Less: Accumulated depreciation and amortization	(305,356)		(294,468)		Less: Accumulated depreciation and amortization	(309,592)		(294,468)
Net, property, plant and equipment	Net, property, plant and equipment	71,335		58,867		Net, property, plant and equipment	72,131		58,867
Construction-in-process	Construction-in-process	54,013		45,236		Construction-in-process	67,967		45,236
Total	Total	$	125,348	$	104,103	Total	$	140,098	$	104,103

Note 1011 — Stockholders’ Equity and Stock-Based Compensation

Common Stock Repurchase Program

On October 26, 2020, our Board of Directors authorized a program to repurchase up to $50 million of outstanding common stock to offset potential dilution from issuances of common stock under our stock-based compensation plans. The share repurchase program will expire on October 28, 2022. During the ~~six~~nine months ended ~~June 26,~~September 25, 2021, we repurchased and retired 620,200 shares of common stock for $24.0 million and, as of ~~June 26,~~September 25, 2021, $26.0 million remained available for future repurchases.

Our policy related to repurchases of our common stock is to charge the excess of cost over par value to additional paid-in capital once the shares are retired. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

Restricted Stock Units

Restricted stock unit (“RSU”) activity under our equity incentive plan was as follows:


		Units	Weighted Average Grant Date Fair Value			Units	Weighted Average Grant Date Fair Value
RSUs at December 26, 2020	RSUs at December 26, 2020	2,840,922	$	19.80	RSUs at December 26, 2020	2,840,922	$	19.80
Awards granted	Awards granted	43,949	36.71		Awards granted	1,030,085	36.09
Awards vested	Awards vested	(451,957)	15.95		Awards vested	(1,457,554)	16.95
Awards forfeited	Awards forfeited	(26,996)	22.66		Awards forfeited	(38,128)	23.82
RSUs at June 26, 2021		2,405,918	20.80
RSUs at September 25, 2021					RSUs at September 25, 2021	2,375,325	28.55

Performance Restricted Stock Units

We may grant Performance RSUs (“PRSUs”) to certain executives, which vest based upon us achieving certain market performance criteria.

On August 2, 2021, we granted 197,128 PRSUs to certain senior executives for a total grant date fair value of $8.6 million, which will be recognized ratably over the requisite service period. The performance criteria are based on Total Shareholder Returns ("TSR") for the period of July 1, 2021 - June 30, 2024, relative to the TSR of the companies identified as being part of the S&P semiconductor Select Industry Index (FormFactor peer companies) as of the grant date.

All 318,100 PRSUs granted in fiscal 2018 vested during the nine months ended September 25, 2021. These shares achieved TSR performance that resulted in an additional 124,600 shares issued during the nine months ended September 25, 2021 related to the 2018 PRSU grant.

There were 0no other PRSUs granted during the ~~six~~nine months ended ~~June 26,~~September 25, 2021. PRSUs are included as part of the RSU activity above.

Stock Options

Stock option activity under our equity incentive plan was as follows:

Options Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Life in Years Aggregate Intrinsic Value
(in thousands)
Outstanding at December 26, 2020 106,000 $ 8.35
Options exercised (100,000) 8.44
Outstanding at June 26, 2021 6,000 $ 6.93 1.11 $ 172
Vested and expected to vest at June 26, 2021 6,000 $ 6.93 1.11 $ 172
Exercisable at June 26, 2021 6,000 $ 6.93 1.11 $ 172


	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value (in thousands)
Outstanding at December 26, 2020	106,000	$	8.35

Options exercised	(100,000)	8.44

Outstanding at September 25, 2021	6,000	$	6.93	0.86	$	201
Vested and expected to vest at September 25, 2021	6,000	$	6.93	0.86	$	201
Exercisable at September 25, 2021	6,000	$	6.93	0.86	$	201

Employee Stock Purchase Plan

Information related to activity under our Employee Stock Purchase Plan (“ESPP”) was as follows:


	~~Six~~Nine Months Ended
	~~June 26,~~September 25, 2021
Shares issued	~~228,784~~378,584
Weighted average per share purchase price	$	~~22.14~~25.91
Weighted average per share discount from the fair value of our common stock on the date of issuance	$	~~(18.73)~~(13.53)

Stock-Based Compensation

Stock-based compensation was included in our Condensed Consolidated Statements of Income as follows (in thousands):


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		June 26, 2021		June 27, 2020		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Cost of revenues	Cost of revenues	$	1,079	$	901	$	2,414	$	1,838	Cost of revenues	$	1,392	$	962	$	3,806	$	2,800
Research and development	Research and development	1,663		1,389		3,352		2,828		Research and development	2,010		1,326		5,362		4,154
Selling, general and administrative	Selling, general and administrative	3,846		3,352		7,899		6,599		Selling, general and administrative	4,518		3,221		12,417		9,820
Total stock-based compensation	Total stock-based compensation	$	6,588	$	5,642	$	13,665	$	11,265	Total stock-based compensation	$	7,920	$	5,509	$	21,585	$	16,774

Unrecognized Compensation Costs

At ~~June 26,~~September 25, 2021, the unrecognized stock-based compensation was as follows (dollars in thousands):


		Unrecognized Expense		Average Expected Recognition Period in Years
						Unrecognized Expense		Average Expected Recognition Period in Years
Restricted stock units	Restricted stock units	$	23,767	1.87	Restricted stock units	$	43,364	2.33
Performance restricted stock units	Performance restricted stock units	6,369		1.77	Performance restricted stock units	13,523		2.28
Employee stock purchase plan	Employee stock purchase plan	243		0.11	Employee stock purchase plan	1,806		0.36
Total unrecognized stock-based compensation expense	Total unrecognized stock-based compensation expense	$	30,379	1.83	Total unrecognized stock-based compensation expense	$	58,693	2.26

Note 1112 — Net Income per Share

The following table reconciles the shares used in calculating basic net income per share and diluted net income per share (in thousands):
Three Months Ended Six Months Ended
June 26,
2021 June 27,
2020 June 26,
2021 June 27,
2020
Weighted-average shares used in computing basic net income per share 77,463 76,275 77,530 76,140
Add potentially dilutive securities 2,003 2,586 2,091 2,570
Weighted-average shares used in computing diluted net income per share 79,466 78,861 79,621 78,710
Securities not included as they would have been antidilutive 128 0 118 13


	Three Months Ended		Nine Months Ended
	September 25, 2021	September 26, 2020	September 25, 2021	September 26, 2020



Weighted-average shares used in computing basic net income per share	77,869	77,029	77,643	76,436
Add potentially dilutive securities	1,160	1,780	1,547	2,098
Weighted-average shares used in computing diluted net income per share	79,029	78,809	79,190	78,534

Securities not included as they would have been antidilutive	121	264	109	354

Note 1213 — Commitments and Contingencies

Leases

See Note ~~13,~~14, Leases.

Contractual Obligations and Commitments

Our contractual obligations and commitments have not materially changed as of ~~June 26,~~September 25, 2021 from those disclosed in our Annual Report on Form 10-K for the year ended December 26, 2020.

Legal Matters

From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. As of ~~June 26,~~September 25, 2021, and as of the filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.

Note 1314 — Leases

We lease real estate space under non-cancelable operating lease agreements for commercial and industrial space, as well as for our corporate headquarters located in Livermore, California. Our leases have remaining terms of 1 to 87 years, and some leases include options to extend up to 20 years. We also have operating leases for automobiles with remaining lease terms of 1 to 4 years. We did not include any of our renewal options in our lease terms for calculating our lease liability as the renewal options allow us to maintain operational flexibility and we are not reasonably certain we will exercise these options at this time. The weighted-average remaining lease term for our operating leases was 6 years as of ~~June 26,~~September 25, 2021 and the weighted-average discount rate was ~~3.70%~~3.72%.

The components of lease expense were as follows (in thousands):


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		June 26, 2021		June 27, 2020		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Lease expense:	Lease expense:									Lease expense:
Operating lease expense	Operating lease expense	$	2,048	$	1,794	$	4,170	$	3,719	Operating lease expense	$	2,167	$	1,818	$	6,338	$	5,536
Short-term lease expense	Short-term lease expense	45		27		83		66		Short-term lease expense	51		32		133		94
Variable lease expense	Variable lease expense	426		399		963		782		Variable lease expense	461		372		1,424		1,159
		$	2,519	$	2,220	$	5,216	$	4,567		$	2,679	$	2,222	$	7,895	$	6,789

Future minimum payments under our non-cancelable operating leases were as follows as of ~~June 26,~~September 25, 2021 (in thousands):
Fiscal Year Amount
Remainder of 2021 $ 4,264
2022 8,527
2023 7,172
2024 6,766
2025 6,742
Thereafter 14,850
  Total minimum lease payments 48,321
Less: interest (6,202)
  Present value of net minimum lease payments 42,119
Less: current portion (7,908)
  Total long-term operating lease liabilities $ 34,211


Fiscal Year	Amount
Remainder of 2021	$	2,116
2022	8,536
2023	7,167
2024	6,744
2025	6,726
Thereafter	14,815
Total minimum lease payments	46,104
Less: interest	(5,741)
Present value of net minimum lease payments	40,363
Less: current portion	(7,962)
Total long-term operating lease liabilities	$	32,401

Note 1415 — Revenue

Transaction price allocated to the remaining performance obligations: On ~~June 26,~~September 25, 2021, we had ~~$10.7~~$10.0 million of remaining performance obligations, which were comprised of deferred service contracts and extended warranty contracts and contracts with overtime revenue recognition that are not yet delivered. We expect to recognize approximately ~~41.2%~~27.9% of our remaining performance obligations as revenue in the remainder of fiscal 2021, approximately ~~43.6%~~55.8% in fiscal 2022, and approximately ~~15.2%~~16.3% in fiscal 2023 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation.

Contract balances: The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for doubtful accounts. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. A contract asset is recorded when we have performed under the contract but our right to consideration is conditional on something other than the passage of time. Contract assets as of ~~June 26,~~September 25, 2021 and December 26, 2020 were ~~$3.6~~$2.4 million and $3.7 million, respectively, and are reported on the Condensed Consolidated Balance Sheets as a component of Prepaid expenses and other current assets.

Contract liabilities include payments received in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets at the end of each reporting period as a component of Deferred revenue and Other liabilities. Contract liabilities as of ~~June 26,~~September 25, 2021 and December 26, 2020 were ~~$23.9~~$24.3 million and $22.2 million, respectively. During the ~~six~~nine months ended ~~June 26,~~September 25, 2021, we recognized ~~$12.8~~$15.0 million of revenue, that was included in contract liabilities as of December 26, 2020.

Costs to obtain a contract: We generally expense sales commissions when incurred as a component of Selling, general and administrative expense, as the amortization period is typically less than one year.

Revenue by Category: Refer to Note ~~15,~~16, Operating Segments and Enterprise-Wide Information, for further details.

Note 1516 — Operating Segments and Enterprise-Wide Information

Our chief operating decision maker (“CODM”) is our Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. We operate in 2 reportable segments consisting

of the Probe Cards segment and the Systems segment. The following table summarizes the operating results by reportable segment (dollars in thousands):

Three Months Ended
June 26, 2021 June 27, 2020
Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total
Revenues $ 153,641 $ 34,435 $ 0 $ 188,076 $ 133,784 $ 24,040 $ 0 $ 157,824
Gross profit $ 66,600 $ 16,907 $ (7,224) $ 76,283 $ 61,523 $ 10,719 $ (6,075) $ 66,167
Gross margin 43.3 % 49.1 % 0 40.6 % 46.0 % 44.6 % 0 41.9 %


		Six Months Ended																							Three Months Ended
		June 26, 2021											June 27, 2020												September 25, 2021											September 26, 2020
		Probe Cards			Systems			Corporate and Other		Total			Probe Cards			Systems			Corporate and Other		Total				Probe Cards			Systems			Corporate and Other		Total			Probe Cards			Systems			Corporate and Other		Total
Revenues	Revenues	$	312,539		$	62,173		$	0	$	374,712		$	268,499		$	50,078		$	0	$	318,577		Revenues	$	154,850		$	35,114		$	—	$	189,964		$	150,773		$	27,223		$	—	$	177,996
Gross profit	Gross profit	$	136,915		$	30,506		$	(14,432)	$	152,989		$	122,266		$	24,053		$	(12,762)	$	133,557		Gross profit	$	69,868		$	17,553		$	(7,202)	$	80,219		$	69,641		$	13,565		$	(6,457)	$	76,749
Gross margin	Gross margin	43.8		%	49.1		%	0		40.8		%	45.5		%	48.0		%	0		41.9		%	Gross margin	45.1		%	50.0		%	0		42.2		%	46.2		%	49.8		%	0		43.1		%

																									Nine Months Ended
																									September 25, 2021											September 26, 2020
																									Probe Cards			Systems			Corporate and Other		Total			Probe Cards			Systems			Corporate and Other		Total
Revenues																								Revenues	$	467,389		$	97,287		$	—	$	564,676		$	419,272		$	77,301		$	—	$	496,573
Gross profit																								Gross profit	$	206,783		$	48,059		$	(21,634)	$	233,208		$	191,907		$	37,618		$	(19,219)	$	210,306
Gross margin																								Gross margin	44.2		%	49.4		%	0		41.3		%	45.8		%	48.7		%	0		42.4		%

Operating results provide useful information to our management for assessment of our performance and results of operations. Certain components of our operating results are utilized to determine executive compensation along with other measures.

Corporate and Other includes unallocated expenses relating to amortization of intangible assets, inventory and fixed asset fair value adjustments due to acquisitions, share-based compensation, and ~~other,~~restructuring charges which are not used in evaluating the results of, or in allocating resources to, our reportable segments.

Certain revenue category information by reportable segment was as follows (in thousands):


		Three Months Ended													Three Months Ended
		June 26, 2021						June 27, 2020							September 25, 2021						September 26, 2020
		Probe Cards		Systems		Total		Probe Cards		Systems		Total			Probe Cards		Systems		Total		Probe Cards		Systems		Total
Market:	Market:													Market:
Foundry & Logic	Foundry & Logic	$	103,726	$	0	$	103,726	$	109,347	$	0	$	109,347	Foundry & Logic	$	104,640	$	—	$	104,640	$	108,411	$	—	$	108,411
DRAM	DRAM	42,088		0		42,088		19,052		0		19,052		DRAM	39,816		—		39,816		31,379		—		31,379
Flash	Flash	7,827		0		7,827		5,385		0		5,385		Flash	10,394		—		10,394		10,983		—		10,983
Systems	Systems	0		34,435		34,435		0		24,040		24,040		Systems	—		35,114		35,114		—		27,223		27,223
Total	Total	$	153,641	$	34,435	$	188,076	$	133,784	$	24,040	$	157,824	Total	$	154,850	$	35,114	$	189,964	$	150,773	$	27,223	$	177,996
Timing of revenue recognition:	Timing of revenue recognition:													Timing of revenue recognition:
Products transferred at a point in time	Products transferred at a point in time	$	153,129	$	30,884	$	184,013	$	133,208	$	22,548	$	155,756	Products transferred at a point in time	$	154,217	$	33,564	$	187,781	$	150,252	$	25,987	$	176,239
Products and services transferred over time	Products and services transferred over time	512		3,551		4,063		576		1,492		2,068		Products and services transferred over time	633		1,550		2,183		521		1,236		1,757
Total	Total	$	153,641	$	34,435	$	188,076	$	133,784	$	24,040	$	157,824	Total	$	154,850	$	35,114	$	189,964	$	150,773	$	27,223	$	177,996
Geographical region:	Geographical region:													Geographical region:
China														China	$	46,011	$	5,036	$	51,047	$	24,851	$	3,695	$	28,546
Taiwan	Taiwan	$	46,737	$	5,147	$	51,884	$	29,806	$	3,365	$	33,171	Taiwan	34,100		7,474		41,574		33,351		3,584		36,935
South Korea	South Korea	35,426		751		36,177		14,249		864		15,113		South Korea	27,895		1,077		28,972		28,337		1,234		29,571
United States	United States	24,174		8,476		32,650		22,368		5,753		28,121		United States	18,530		6,938		25,468		31,596		4,732		36,328
China		23,996		7,831		31,827		45,625		3,133		48,758
Asia-Pacific1	Asia-Pacific1	12,569		1,719		14,288		4,347		2,153		6,500		Asia-Pacific1	18,566		1,315		19,881		5,505		3,449		8,954
Japan														Japan	5,767		4,961		10,728		12,288		4,857		17,145
Europe	Europe	6,466		5,544		12,010		8,767		5,365		14,132		Europe	3,595		6,891		10,486		11,679		5,300		16,979
Japan		3,477		4,227		7,704		6,679		3,380		10,059
Rest of the world	Rest of the world	796		740		1,536		1,943		27		1,970		Rest of the world	386		1,422		1,808		3,166		372		3,538
Total	Total	$	153,641	$	34,435	$	188,076	$	133,784	$	24,040	$	157,824	Total	$	154,850	$	35,114	$	189,964	$	150,773	$	27,223	$	177,996

2423


		Six Months Ended													Nine Months Ended
		June 26, 2021						June 27, 2020							September 25, 2021						September 26, 2020
		Probe Cards		Systems		Total		Probe Cards		Systems		Total			Probe Cards		Systems		Total		Probe Cards		Systems		Total
Market:	Market:													Market:
Foundry & Logic	Foundry & Logic	$	217,136	$	0	$	217,136	$	215,092	$	0	$	215,092	Foundry & Logic	$	321,776	$	—	$	321,776	$	323,503	$	—	$	323,503
DRAM	DRAM	75,986		0		75,986		43,748		0		43,748		DRAM	115,802		—		115,802		75,127		—		75,127
Flash	Flash	19,417		0		19,417		9,659		0		9,659		Flash	29,811		—		29,811		20,642		—		20,642
Systems	Systems	0		62,173		62,173		0		50,078		50,078		Systems	—		97,287		97,287		—		77,301		77,301
Total	Total	$	312,539	$	62,173	$	374,712	$	268,499	$	50,078	$	318,577	Total	$	467,389	$	97,287	$	564,676	$	419,272	$	77,301	$	496,573
Timing of revenue recognition:	Timing of revenue recognition:													Timing of revenue recognition:
Products transferred at a point in time	Products transferred at a point in time	$	311,605	$	55,555	$	367,160	$	267,277	$	47,406	$	314,683	Products transferred at a point in time	$	465,822	$	89,119	$	554,941	$	417,529	$	73,393	$	490,922
Products and services transferred over time	Products and services transferred over time	934		6,618		7,552		1,222		2,672		3,894		Products and services transferred over time	1,567		8,168		9,735		1,743		3,908		5,651
Total	Total	$	312,539	$	62,173	$	374,712	$	268,499	$	50,078	$	318,577	Total	$	467,389	$	97,287	$	564,676	$	419,272	$	77,301	$	496,573
Geographical region:	Geographical region:													Geographical region:
Taiwan	Taiwan	$	91,471	$	5,993	$	97,464	$	60,245	$	4,706	$	64,951	Taiwan	$	125,571	$	13,467	$	139,038	$	93,596	$	8,290	$	101,886
China	China	61,827		12,625		74,452		82,905		9,495		92,400		China	107,838		17,661		125,499		107,756		13,190		120,946
United States	United States	45,482		16,654		62,136		47,979		12,058		60,037		United States	64,012		23,592		87,604		79,575		16,790		96,365
South Korea	South Korea	53,427		1,835		55,262		27,941		1,260		29,201		South Korea	81,322		2,912		84,234		56,278		2,494		58,772
Asia-Pacific1	Asia-Pacific1	40,447		2,799		43,246		8,802		5,561		14,363		Asia-Pacific1	59,013		4,114		63,127		14,307		9,010		23,317
Europe	Europe	9,299		12,710		22,009		24,977		10,198		35,175		Europe	12,894		19,601		32,495		36,656		15,498		52,154
Japan	Japan	8,726		8,299		17,025		12,214		6,215		18,429		Japan	14,493		13,260		27,753		24,502		11,072		35,574
Rest of the world	Rest of the world	1,860		1,258		3,118		3,436		585		4,021		Rest of the world	2,246		2,680		4,926		6,602		957		7,559
Total	Total	$	312,539	$	62,173	$	374,712	$	268,499	$	50,078	$	318,577	Total	$	467,389	$	97,287	$	564,676	$	419,272	$	77,301	$	496,573

1 Asia-Pacific includes all countries in the region except China, Japan, South Korea, and Taiwan, which are disclosed separately.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, which are subject to risks and uncertainties. The forward-looking statements include statements concerning, among other things, our business strategy, financial and operating results, gross margins, liquidity and capital expenditure requirements and impact of accounting standards. In some cases, you can identify these statements by forward-looking words, such as “may,” “might,” “will,” “could,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “intend” and “continue,” the negative or plural of these words and other comparable terminology.

The forward-looking statements are only predictions based on our current expectations and our projections about future events. All forward-looking statements included in this Quarterly Report on Form 10-Q are based upon information available to us as of the filing date of this Quarterly Report on Form 10-Q. You should not place undue reliance on these forward-looking statements. We have no obligation to update any of these statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements, including risks related to general market trends, the benefits of acquisitions and investments, our supply chain, uncertainties related to COVID-19 and the impact of our responses to it, the interpretation and impacts of changes in export controls and other trade barriers, our ability to execute our business strategy and other risks discussed in the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 26, 2020 and in this Quarterly Report on Form 10-Q. You should carefully consider the numerous risks and uncertainties described under these sections.

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and the accompanying notes contained in this Quarterly Report on Form 10-Q. Unless expressly stated or the context otherwise requires, the terms “we,” “our,” “us” and “FormFactor” refer to FormFactor, Inc. and its subsidiaries.

2524

Overview

FormFactor, Inc., headquartered in Livermore, California, is a leading provider of test and measurement technologies. We provide a broad range of high-performance probe cards, analytical probes, probe stations, metrology systems, thermal systems and cryogenic systems to both semiconductor companies and scientific institutions. Our products provide electrical and physical information from a variety of semiconductor and electro-optical devices and integrated circuits from early research, through development, to high-volume production. Customers use our products and services to lower production costs, improve yields, and enable development of their complex next-generation products.

We operate in two reportable segments consisting of the Probe Cards segment and the Systems segment. Sales of our probe cards and analytical probes are included in the Probe Cards segment, while sales of our probe stations, metrology systems, and thermal and cryogenic systems are included in the Systems segment.

We generated net income of ~~$37.5~~$58.0 million in the first ~~six~~nine months of fiscal 2021 as compared to ~~$36.4~~$59.3 million in the first ~~six~~nine months of fiscal 2020. The ~~increase~~small decrease in net income was primarily due to increased revenues, partially offset by slightly lower margins on a lower mix of Foundry & Logic probe card sales and higher ~~operating expenses~~taxes on higher ~~operating levels.~~taxable income and a higher tax rate due to significant one-time tax benefits during 2020.

Impact of COVID-19

The COVID-19 pandemic continues to cause serious illness and death in many of the regions that we, our customers and our suppliers operate. The COVID-19 pandemic has resulted in significant governmental actions designed to control the spread of the virus, including the imposition of safety requirements and other orders in locations where we have manufacturing and other activities.

We believe that we operate in a critical infrastructure industry, as defined by the U.S. Department of Homeland Security. This reduces the current and anticipated impacts of the COVID-19 pandemic on our major customers and suppliers, and upon our operations, as compared to companies that are not part of the critical infrastructure. We currently continue to operate in all of our manufacturing sites at production levels comparable to those prior to the pandemic, albeit subject to certain safety and related constraints. Our other operations are similarly continuing with substantial work-from-home activities.

If the provisions of governmental health orders or other safety requirements applicable to us or our customers or suppliers become more restrictive for an extended period of time, or if we have repeated occurrences of COVID-19 in any of our facilities, we may experience disruptions or delays in manufacturing, product design, product development, customer support, manufacturing and sales, and an overall loss of productivity and efficiency.

While to date the disruptions in our operations, supply chain and customer demand as a result of the COVID-19 pandemic have been somewhat limited, we believe that the COVID-19 pandemic represents a sustained threat that may give rise to a variety of more significant adverse impacts on our business and financial results. For a further description of the uncertainties and business risks associated with the COVID-19 pandemic, see the risk factors discussed in our Annual Report on Form 10-K for the year ended December 26, 2020.

Significant Accounting Policies and the Use of Estimates

Management’s Discussion and Analysis and Note 2, Summary of Significant Accounting Policies, to the Consolidated Financial Statements in our 2020 Annual Report on Form 10-K describe the significant accounting estimates and significant accounting policies used in preparation of the Consolidated Financial Statements. Actual results in these areas could differ from management’s estimates. During the ~~six~~nine months ended ~~June 26,~~September 25, 2021, there were no significant changes in our significant accounting policies or estimates from those reported in our Annual Report on Form 10-K for the year ended December 26, 2020, which was filed with the Securities and Exchange Commission on February 22, 2021.

2625

Results of Operations

The following table sets forth our operating results as a percentage of revenues for the periods indicated:


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		June 26, 2021		June 27, 2020		June 26, 2021		June 27, 2020			September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Revenues	Revenues	100.0	%	100.0	%	100.0	%	100.0	%	Revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of revenues	Cost of revenues	59.4		58.1		59.2		58.1		Cost of revenues	57.8		56.9		58.7		57.6
Gross profit	Gross profit	40.6		41.9		40.8		41.9		Gross profit	42.2		43.1		41.3		42.4
Operating expenses:	Operating expenses:									Operating expenses:
Research and development	Research and development	13.5		13.3		13.2		13.2		Research and development	13.7		12.9		13.4		13.1
Selling, general and administrative	Selling, general and administrative	16.2		14.4		16.1		15.8		Selling, general and administrative	16.3		17.9		16.2		16.6

Total operating expenses	Total operating expenses	29.7		27.7		29.3		29.0		Total operating expenses	30.0		30.8		29.6		29.7
Operating income	Operating income	10.9		14.2		11.5		12.9		Operating income	12.2		12.3		11.7		12.7
Interest income	Interest income	0.1		0.2		0.1		0.3		Interest income	0.1		0.1		0.1		0.3
Interest expense	Interest expense	(0.1)		(0.1)		(0.1)		(0.2)		Interest expense	(0.1)		(0.1)		(0.1)		(0.1)
Other expense, net	Other expense, net	(0.1)		—		—		—		Other expense, net	0.1		0.2		—		—
Income before income taxes	Income before income taxes	10.8		14.3		11.5		13.0		Income before income taxes	12.3		12.5		11.7		12.9
Provision for income taxes		1.2		1.4		1.5		1.6
Provision (benefit) for income taxes										Provision (benefit) for income taxes	1.5		(0.3)		1.4		0.9
Net income	Net income	9.6	%	12.9	%	10.0	%	11.4	%	Net income	10.8	%	12.8	%	10.3	%	12.0	%

Revenues by Segment and Market


											Three Months Ended				Nine Months Ended
		Three Months Ended				Six Months Ended					September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
		June 26, 2021		June 27, 2020		June 26, 2021		June 27, 2020
		(In thousands)									(In thousands)
Probe Cards	Probe Cards	$	153,641	$	133,784	$	312,539	$	268,499	Probe Cards	$	154,850	$	150,773	$	467,389	$	419,272
Systems	Systems	34,435		24,040		62,173		50,078		Systems	35,114		27,223		97,287		77,301
		$	188,076	$	157,824	$	374,712	$	318,577		$	189,964	$	177,996	$	564,676	$	496,573

2726


															Three Months Ended
		Three Months Ended													September 25, 2021		% of Revenues		September 26, 2020		% of Revenues		$ Change		% Change
		June 26, 2021		% of Revenues		June 27, 2020		% of Revenues		$ Change		% Change
		(Dollars in thousands)													(Dollars in thousands)
Probe Cards Markets:	Probe Cards Markets:													Probe Cards Markets:
Foundry & Logic	Foundry & Logic	$	103,726	55.1	%	$	109,347	69.3	%	$	(5,621)	(5.1)	%	Foundry & Logic	$	104,640	55.1	%	$	108,411	60.9	%	$	(3,771)	(3.5)	%
DRAM	DRAM	42,088		22.4		19,052		12.1		23,036		120.9		DRAM	39,816		20.9		31,379		17.6		8,437		26.9
Flash	Flash	7,827		4.2		5,385		3.4		2,442		45.3		Flash	10,394		5.5		10,983		6.2		(589)		(5.4)
Systems Market:	Systems Market:													Systems Market:
Systems	Systems	34,435		18.3		24,040		15.2		10,395		43.2		Systems	35,114		18.5		27,223		15.3		7,891		29.0
Total revenues	Total revenues	$	188,076	100.0	%	$	157,824	100.0	%	$	30,252	19.2	%	Total revenues	$	189,964	100.0	%	$	177,996	100.0	%	$	11,968	6.7	%

		Six Months Ended													Nine Months Ended
		June 26, 2021		% of Revenues		June 27, 2020		% of Revenues		$ Change		% Change			September 25, 2021		% of Revenues		September 26, 2020		% of Revenues		$ Change		% Change
		(Dollars in thousands)
															(Dollars in thousands)
Probe Cards Markets:	Probe Cards Markets:													Probe Cards Markets:
Foundry & Logic	Foundry & Logic	$	217,136	57.9	%	$	215,092	67.6	%	$	2,044	1.0	%	Foundry & Logic	$	321,776	57.0	%	$	323,503	65.1	%	$	(1,727)	(0.5)	%
DRAM	DRAM	75,986		20.3		43,748		13.7		32,238		73.7		DRAM	115,802		20.5		75,127		15.1		40,675		54.1
Flash	Flash	19,417		5.2		9,659		3.0		9,758		101.0		Flash	29,811		5.3		20,642		4.2		9,169		44.4
Systems Market:	Systems Market:													Systems Market:
Systems	Systems	62,173		16.6		50,078		15.7		12,095		24.2		Systems	97,287		17.2		77,301		15.6		19,986		25.9
Total revenues	Total revenues	$	374,712	100.0	%	$	318,577	100.0	%	$	56,135	17.6	%	Total revenues	$	564,676	100.0	%	$	496,573	100.0	%	$	68,103	13.7	%

The decrease in Foundry & Logic product revenue for the three months ended ~~June 26,~~September 25, 2021, compared to the three months ended ~~June 27,~~September 26, 2020, was driven ~~principally~~by lower demand from two major customers, partially offset by increased unit sales to other large semiconductor foundries and integrated device manufacturers. The decrease for the nine months ended September 25, 2021, compared to the nine months ended September 26, 2020, was driven by lower demand from one major customer, partially offset by increased unit sales to other large semiconductor foundries and integrated device ~~manufacturers, demonstrating success in diversifying across~~manufacturers. The relative stability of our ~~strategic accounts. The increase in Foundry & Logic product~~overall revenue, ~~for~~despite these fluctuations, is the ~~six months ended June 26, 2021, compared to the six months ended June 27, 2020, was driven principally by increased unit sales to large semiconductor foundries~~result of our long-term customer and ~~integrated device manufacturers, partially offset by lower demand from one major customer.~~market diversification initiatives.

The increase in DRAM product revenue for the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021, compared to the three and ~~six~~nine months ended ~~June 27,~~September 26, 2020, was driven by ~~an increase in~~increased sales ~~as a result~~to several customers and strong market-based demand for DRAM products through the first three quarters of ~~increased design wins and customer demand.~~fiscal 2021.

Flash product revenue was down slightly for the three months ended September 25, 2021, compared to the three months ended September 26, 2020, with shifts between customers that are typical as our revenue in this market continues to be highly variable. The increase in Flash product revenue for the ~~three and six~~nine months ended ~~June 26,~~September 25, 2021, compared to the ~~three and six~~nine months ended ~~June 27,~~September 26, 2020, was driven by increased sales resulting from the acquisition of Baldwin ~~Park. Our revenue in this market continues to be highly variable.~~Park offset by decreased sales as a result of decreased customer demand for our existing products.

The increase in Systems product revenue for the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021, compared to the three and ~~six~~nine months ended ~~June 27,~~September 26, 2020, was driven by increased sales of cryogenic systems due to the acquisition of High Precision Devices, Inc. (“HPD”) and increased sales of thermal sub-systems and metrology systems.

Due to COVID-19, there were various impacts across our segments due to governmental mandates of social distancing. This resulted in a temporary factory shutdown for almost two weeks during our first fiscal quarter of 2020 in certain locations, limiting our manufacturing capacity. We believe these shutdowns negatively affected revenue and impacted our ability to maintain typical lead times, especially in our Probes segment. The plant shutdowns we experienced in the six months ended June 27, 2020 did not recur in the six months ended June 26, 2021, which presumably drove some of the increased sales, particularly in the Probe Cards segment where the plant shutdowns in 2020 were longer in duration than the shutdowns for the Systems segment.

2827

Revenues by Geographic Region
Three Months Ended Six Months Ended
June 26,
2021 % of
Revenue June 27,
2020 % of
Revenue June 26,
2021 % of
Revenue June 27,
2020 % of
Revenue
(Dollars in thousands)
Taiwan $ 51,884 27.6 % $ 33,171 21.0 % $ 97,464 26.0 % $ 64,951 20.4 %
South Korea 36,177 19.2 % 15,113 9.6 % 55,262 14.7 % 29,201 9.2 %
United States 32,650 17.4 % 28,121 17.8 % 62,136 16.6 % 60,037 18.8 %
China 31,827 16.9 % 48,758 30.9 % 74,452 19.9 % 92,400 29.0 %
Asia-Pacific1
14,288 7.6 % 6,500 4.1 % 43,246 11.5 % 14,363 4.5 %
Europe 12,010 6.4 % 14,132 9.0 % 22,009 5.9 % 35,175 11.0 %
Japan 7,704 4.1 % 10,059 6.4 % 17,025 4.5 % 18,429 5.8 %
Rest of the world 1,536 0.8 % 1,970 1.2 % 3,118 0.9 % 4,021 1.3 %
Total revenues $ 188,076 100.0 % $ 157,824 100.0 % $ 374,712 100.0 % $ 318,577 100.0 %


	Three Months Ended								Nine Months Ended
	September 25, 2021		% of Revenue		September 26, 2020		% of Revenue		September 25, 2021		% of Revenue		September 26, 2020		% of Revenue

	(Dollars in thousands)
Taiwan	$	41,574	21.9	%	$	36,935	20.8	%	$	139,038	24.6	%	$	101,886	20.5	%
China	51,047		26.8		28,546		16.0		125,499		22.2		120,946		24.4
United States	25,468		13.4		36,328		20.4		87,604		15.5		96,365		19.4
South Korea	28,972		15.3		29,571		16.6		84,234		14.9		58,772		11.8
Asia-Pacific1	19,881		10.5		8,954		5.0		63,127		11.2		23,317		4.7
Europe	10,486		5.5		16,979		9.5		32,495		5.8		52,154		10.5
Japan	10,728		5.6		17,145		9.6		27,753		4.9		35,574		7.2
Rest of the world	1,808		1.0		3,538		2.1		4,926		0.9		7,559		1.5
Total revenues	$	189,964	100.0	%	$	177,996	100.0	%	$	564,676	100.0	%	$	496,573	100.0	%

1 Asia-Pacific includes all countries in the region except China, Japan, South Korea and Taiwan, which are disclosed separately.

Geographic revenue information is based on the location to which we ship the product. For example, if a certain South Korean customer purchases through their U.S. subsidiary and requests the products to be shipped to an address in South Korea, this sale will be reflected in the revenue for South Korea rather than the U.S.

Changes in revenue by geographic region for the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021, compared to the three and ~~six~~nine months ended ~~June 27,~~September 26, 2020, were primarily attributable to changes in customer demand, shifts in customer regional manufacturing strategies, particularly with our large multinational customers, and product sales mix.

Cost of Revenues and Gross Margins

Cost of revenues consists primarily of manufacturing materials, compensation and benefits, shipping and handling costs, manufacturing-related overhead and amortization of certain intangible assets. Our manufacturing operations rely on a limited number of suppliers to provide key components and materials for our products, some of which are a sole source. We order materials and supplies based on backlog and forecasted customer orders. Tooling and setup costs related to changing manufacturing lots at our suppliers are also included in the cost of revenues. We expense all warranty costs, inventory provisions and amortization of certain intangible assets as cost of revenues.

Our gross profit and gross margin were as follows (dollars in thousands):


		Three Months Ended											Three Months Ended
		June 26, 2021			June 27, 2020			$ Change		% Change			September 25, 2021			September 26, 2020			$ Change		% Change
Gross profit	Gross profit	$	76,283		$	66,167		$	10,116	15.3	%	Gross profit	$	80,219		$	76,749		$	3,470	4.5	%
Gross margin	Gross margin	40.6		%	41.9		%					Gross margin	42.2		%	43.1		%

		Six Months Ended											Nine Months Ended
		June 26, 2021			June 27, 2020			$ Change		% Change			September 25, 2021			September 26, 2020			$ Change		% Change
Gross profit	Gross profit	$	152,989		$	133,557		$	19,432	14.5	%	Gross profit	$	233,208		$	210,306		$	22,902	10.9	%
Gross margin	Gross margin	40.8		%	41.9		%					Gross margin	41.3		%	42.4		%

2928

Our gross profit and gross margin by segment were as follows (dollars in thousands):


		Three Months Ended																							Three Months Ended
		June 26, 2021											June 27, 2020												September 25, 2021											September 26, 2020
		Probe Cards			Systems			Corporate and Other		Total			Probe Cards			Systems			Corporate and Other		Total				Probe Cards			Systems			Corporate and Other		Total			Probe Cards			Systems			Corporate and Other		Total
Gross profit	Gross profit	$	66,600		$	16,907		$	(7,224)	$	76,283		$	61,523		$	10,719		$	(6,075)	$	66,167		Gross profit	$	69,868		$	17,553		$	(7,202)	$	80,219		$	69,641		$	13,565		$	(6,457)	$	76,749
Gross margin	Gross margin	43.3		%	49.1		%			40.6		%	46.0		%	44.6		%			41.9		%	Gross margin	45.1		%	50.0		%			42.2		%	46.2		%	49.8		%			43.1		%

		Six Months Ended																							Nine Months Ended
		June 26, 2021											June 27, 2020												September 25, 2021											September 26, 2020
		Probe Cards			Systems			Corporate and Other		Total			Probe Cards			Systems			Corporate and Other		Total				Probe Cards			Systems			Corporate and Other		Total			Probe Cards			Systems			Corporate and Other		Total
Gross profit	Gross profit	$136,915			$	30,506		$	(14,432)	$	152,989		$122,266			$	24,053		$	(12,762)	$	133,557		Gross profit	$206,783			$	48,059		$	(21,634)	$	233,208		$191,907			$	37,618		$	(19,219)	$	210,306
Gross margin	Gross margin	43.8		%	49.1		%			40.8		%	45.5		%	48.0		%			41.9		%	Gross margin	44.2		%	49.4		%			41.3		%	45.8		%	48.7		%			42.4		%

Probe Cards

For the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021, gross margins decreased compared to the three and ~~six~~nine months ended ~~June 27,~~September 26, 2020, primarily due to ~~a lesser proportion of sales coming from~~ higher ~~gross margin~~material costs driven by fluctuations in commodity costs, somewhat offset by higher standard margins on Foundry & Logic ~~probe card sales and a greater proportion of sales coming from lower gross margin DRAM sales, combined with higher materials costs.~~sales.

Systems

For the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021, gross margins increased compared to the three and ~~six~~nine months ended ~~June 27,~~September 26, 2020, primarily as a result of favorable product mix, largely related to increased sales of metrology systems and thermal ~~sub-systems and metrology systems.~~sub-systems.

Corporate and Other

Corporate and Other includes unallocated expenses relating to share-based compensation and amortization of intangible assets, inventory and fixed asset fair value adjustments due to acquisitions, and ~~other~~restructuring which are not used in evaluating the results of, or in allocating resources to, our reportable segments.

Overall

Gross profit and gross margins fluctuate with revenue levels, product mix, selling prices, factory loading and material costs. For the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021, compared to the three and ~~six~~nine months ended ~~June 27,~~September 26, 2020, gross profit has increased on greater revenue levels while gross margins have decreased, primarily on ~~less~~higher material costs, partially offset by a more favorable ~~Probes segment~~ product mix.

Cost of revenues included stock-based compensation expense as follows (in thousands):

Three Months Ended Six Months Ended
June 26,
2021 June 27,
2020 June 26,
2021 June 27,
2020
Stock-based compensation $ 1,079 $ 901 $ 2,414 $ 1,838


	Three Months Ended				Nine Months Ended
	September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Stock-based compensation	$	1,392	$	962	$	3,806	$	2,800

3029

Research and Development


													Three Months Ended
		Three Months Ended											September 25, 2021			September 26, 2020			$ Change		% Change
		June 26, 2021			June 27, 2020			$ Change		% Change
		(Dollars in thousands)											(Dollars in thousands)
Research and development	Research and development	$	25,454		$	20,919		$	4,535	21.7	%	Research and development	$	26,026		$	22,878		$	3,148	13.8	%
% of revenues	% of revenues	13.5		%	13.3		%					% of revenues	13.7		%	12.9		%

		Six Months Ended											Nine Months Ended
		June 26, 2021			June 27, 2020			$ Change		% Change			September 25, 2021			September 26, 2020			$ Change		% Change
		(Dollars in thousands)
													(Dollars in thousands)
Research and development	Research and development	$	49,500		$	42,186		$	7,314	17.3	%	Research and development	$	75,526		$	65,064		$	10,462	16.1	%
% of revenues	% of revenues	13.2		%	13.2		%					% of revenues	13.4		%	13.1		%

The increase in research and development expenses in the three and ~~six~~nine months ended ~~June~~September 25, 2021 when compared to the corresponding period in the prior year was primarily driven by our recent acquisitions of Baldwin Park and HPD, which increased headcount and general operational costs. Annual salary increases, higher stock-based compensation, and restructuring charges also contributed to the increase.

A detail of the changes is as follows (in thousands):


	Three Months Ended September 25, 2021 compared to Three Months Ended September 26, 2020		Nine Months Ended September 25, 2021 compared to Nine Months Ended September 26, 2020
Employee compensation costs	$	1,330	$	5,354
Stock-based compensation	684		1,208
Restructuring charges	289		694
Project material costs	(129)		381
Depreciation	(21)		239
Other general operations	995		2,586
	$	3,148	$	10,462

Research and development included stock-based compensation expense as follows (in thousands):


	Three Months Ended				Nine Months Ended
	September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Stock-based compensation	$	2,010	$	1,326	$	5,362	$	4,154

Selling, General and Administrative


	Three Months Ended
	September 25, 2021			September 26, 2020			$ Change		% Change

	(Dollars in thousands)
Selling, general and administrative	$	30,940		$	31,834		$	(894)	(2.8)	%
% of revenues	16.3		%	17.9		%

	Nine Months Ended
	September 25, 2021			September 26, 2020			$ Change		% Change

	(Dollars in thousands)
Selling, general and administrative	$	91,434		$	82,282		$	9,152	11.1	%
% of revenues	16.2		%	16.6		%

The decrease in selling, general and administrative expenses in the three months ended September 25, 2021 when compared to the corresponding period in the prior year was primarily driven by decreased information technology security remediation costs that were incurred during the three months ended September 26, 2020 that did not repeat. This decrease was partially offset by higher stock-based compensation.

The increase in selling, general and administrative expenses in the nine months ended September 25, 2021 when compared to the corresponding period in the prior year was primarily driven by our recent acquisitions of Baldwin Park and HPD, which increased headcount and general operational costs. Annual salary increases and higher stock-based compensation also contributed to the ~~increase. The increase is in alignment with current operating levels with no change as a percent of revenues for~~increases. These increases were partially offset by the ~~six months ended June 26, 2021 when compared to the corresponding period in the prior year.~~

~~A detail of the changes is as follows (in thousands):~~

Three Months Ended June 26, 2021 compared to Three Months Ended June 27, 2020 Six Months Ended June 26, 2021 compared to Six Months Ended June 27, 2020
Employee compensation costs $ 2,992 $ 4,429
Stock-based compensation 274 524
Project material costs 206 510
Depreciation 146 260
Other general operations 917 1,591
$ 4,535 $ 7,314

~~Research and development included stock-based compensation expense as follows (in thousands):~~

Three Months Ended Six Months Ended
June 26,
2021 June 27,
2020 June 26,
2021 June 27,
2020
Stock-based compensation $ 1,663 $ 1,389 $ 3,352 $ 2,828

~~Selling, General and Administrative~~

Three Months Ended
June 26,
2021 June 27,
2020 $ Change % Change
(Dollars in thousands)
Selling, general and administrative $ 30,479 $ 22,755 $ 7,724 33.9 %
% of revenues 16.2 % 14.4 %
Six Months Ended
June 26,
2021 June 27,
2020 $ Change % Change
(Dollars in thousands)
Selling, general and administrative $ 60,494 $ 50,448 $ 10,046 19.9 %
% of revenues 16.1 % 15.8 %

The increase in selling, general and administrative expenses in the three and six months ended June 26, 2021 when compared to the corresponding period in the prior year was primarily driven by our recent acquisitions of Baldwin Park and HPD, which increased headcount and general operational costs. Annual salary increases and higher stock-based compensation also contributed to the increase, together with a benefit in the prior year related to adjustments to contingent consideration for the acquisition of FRT GmbH ("FRT") and information technology security remediation costs that both did not repeat.

A detail of the changes is as follows (in thousands):


		Three Months Ended June 26, 2021 compared to Three Months Ended June 27, 2020		Six Months Ended June 26, 2021 compared to Six Months Ended June 27, 2020			Three Months Ended September 25, 2021 compared to Three Months Ended September 26, 2020		Nine Months Ended September 25, 2021 compared to Nine Months Ended September 26, 2020
Employee compensation costs						Employee compensation costs	$	331	$	5,235
Gain on contingent consideration	Gain on contingent consideration	$	3,605	$	3,605	Gain on contingent consideration	71		3,676
Employee compensation costs		2,831		4,903
Consulting fees						Consulting fees	(3,368)		(3,402)
Stock-based compensation	Stock-based compensation	494		1,300		Stock-based compensation	1,297		2,597
General operating expenses	General operating expenses	488		506		General operating expenses	562		1,066
Consulting fees		145		(34)
Travel related costs	Travel related costs	100		(498)		Travel related costs	156		(341)
Amortization of intangibles	Amortization of intangibles	61		264		Amortization of intangibles	57		321
		$	7,724	$	10,046		$	(894)	$	9,152

Selling, general and administrative included stock-based compensation expense as follows (in thousands):

Three Months Ended Six Months Ended
June 26,
2021 June 27,
2020 June 26,
2021 June 27,
2020
Stock-based compensation $ 3,846 $ 3,352 $ 7,899 $ 6,599


	Three Months Ended				Nine Months Ended
	September 25, 2021		September 26, 2020		September 25, 2021		September 26, 2020
Stock-based compensation	$	4,518	$	3,221	$	12,417	$	9,820

3231

Interest Income and Interest Expense


															Three Months Ended						Nine Months Ended
		Three Months Ended						Six Months Ended							September 25, 2021			September 26, 2020			September 25, 2021			September 26, 2020
		June 26, 2021			June 27, 2020			June 26, 2021			June 27, 2020
		(Dollars in thousands)													(Dollars in thousands)
Interest Income	Interest Income	$	148		$	376		$	342		$	1,061		Interest Income	$	121		$	249		$	463		$	1,310
Weighted average balance of cash and investments	Weighted average balance of cash and investments	$	263,363		$	235,888		$	215,232		$	223,340		Weighted average balance of cash and investments	$	257,851		$	243,615		$	262,475		$	230,098
Weighted average yield on cash and investments	Weighted average yield on cash and investments	0.32		%	0.81		%	0.35		%	1.26		%	Weighted average yield on cash and investments	0.26		%	0.57		%	0.32		%	1.03		%

Interest Expense	Interest Expense	$	116		$	171		$	296		$	489		Interest Expense	$	151		$	193		$	447		$	682
Average debt outstanding	Average debt outstanding	$	30,453		$	32,368		$	31,358		$	38,843		Average debt outstanding	$	27,810		$	37,295		$	30,214		$	38,327
Weighted average interest rate on debt	Weighted average interest rate on debt	1.58		%	1.92		%	1.58		%	2.26		%	Weighted average interest rate on debt	1.59		%	1.65		%	1.58		%	2.05		%

Interest income is earned on our cash, cash equivalents, restricted cash and marketable securities. The decrease in interest income for the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021 compared with the corresponding period of the prior year was attributable to lower investment yields due to the low interest rate environment, despite higher invested balances.

Interest expense primarily includes interest on our term loans, interest rate swap derivative contracts, and term loan issuance costs amortization charges. The decrease in interest expense for the three and ~~six~~nine months ended ~~June 26,~~September 25, 2021 compared to the same period of the prior year was primarily due to lower outstanding debt balances due to the June 30, 2020 pay-off of the term loan ~~acquired when we purchased~~originated to acquire Cascade Microtech, Inc, ~~and subsequently paid off on June 30, 2020,~~ partially offset by the Building Term Loan ~~that~~ originated in the second quarter of 2020. Interest expense was also lower due to lower average interest rates on the outstanding debt.

Other Income (Expense), Net

Other income (expense), net, primarily includes the effects of foreign currency impact and various other gains and losses.

Provision for Income Taxes


		Three Months Ended						Six Months Ended							Three Months Ended						Nine Months Ended
		June 26, 2021			June 27, 2020			June 26, 2021			June 27, 2020				September 25, 2021			September 26, 2020			September 25, 2021			September 26, 2020
		(In thousands, except percentages)
Provision for income taxes		$	2,283		$	2,162		$	5,489		$	4,978
															(In thousands, except percentages)
Provision (benefit) for income taxes														Provision (benefit) for income taxes	$	2,784		$	(499)		$	8,273		$	4,479
Effective tax rate	Effective tax rate	11.3		%	9.6		%	12.8		%	12.0		%	Effective tax rate	12.0		%	(2.2)		%	12.5		%	7.0		%

Provision for income taxes reflects the tax provision on our operations in foreign and U.S. jurisdictions, offset by tax benefits from tax credits and the foreign-derived intangible income (“FDII”) deduction. Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, changes in ASC 718 stock-based compensation expense/benefit, future expansion into areas with varying country, state, and local income tax rates, and deductibility of certain costs and expenses by jurisdiction. We have utilized our previous net operating loss carryforwards, and expect the FDII deduction and corresponding benefit to be available, resulting in a decrease from the U.S. statutory rate and included in our worldwide effective tax rate for the year ending December 25, 2021.

The increase in the effective tax rate in the nine months ended September 25, 2021 when compared to the corresponding period in the prior year was primarily driven by the cumulative effect of adjustments made related to final and proposed Treasury regulations during the third quarter ended September 26, 2020. The regulations under Sections 951A and 954 provided final global intangible low-taxed income (GILTI) high-tax exclusion and proposed changes to the existing subpart F income high-tax exception, respectively. The impact of those adjustments provided a significant one time tax benefit during 2020.

Liquidity and Capital Resources

Capital Resources

Our working capital was ~~$343.6~~$346.5 million at ~~June 26,~~September 25, 2021, compared to $332.5 million at December 26, 2020.

Cash and cash equivalents primarily consist of deposits held at banks, ~~and~~ money market ~~funds.~~funds, and U.S. treasuries. Marketable securities primarily consist of U.S. treasuries, corporate bonds, and commercial paper. We typically invest in highly-rated

securities with low probabilities of default. Our investment policy requires investments to be rated single A or better, and limits the types of acceptable investments, issuer concentration and duration of the investment.

Our cash, cash equivalents and marketable securities totaled approximately ~~$256.2~~$264.7 million at ~~June 26,~~September 25, 2021, compared to $255.0 million at December 26, 2020. We believe that we will be able to satisfy our working capital requirements and scheduled term loan repayments for at least the next twelve months with the liquidity provided by our existing cash, cash equivalents, marketable securities and cash provided by operations. To the extent necessary, we may consider entering into short and long-term debt obligations, raising cash through a stock issuance, or obtaining new financing facilities, which may not be available on terms favorable to us. Our future capital requirements may vary materially from those now planned.

The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition.

If we are unsuccessful in maintaining or growing our revenues, maintaining or reducing our cost structure (in response to a potential reduction in demand due to an industry downturn, COVID-19, or other event), or increasing our available cash through debt or equity financings, our cash, cash equivalents and marketable securities may decline.

We utilize a variety of tax planning and financing strategies to manage our worldwide cash and deploy funds to locations where needed. As part of these strategies, we indefinitely reinvest a portion of our foreign earnings. Should we require additional capital in the United States, we may elect to repatriate indefinitely-reinvested foreign funds or raise capital in the United States.

Cash Flows

The following table sets forth our net cash flows from operating, investing and financing activities:


							Nine Months Ended
		Six Months Ended					September 25, 2021		September 26, 2020
		June 26, 2021		June 27, 2020
		(In thousands)					(In thousands)
Net cash provided by operating activities	Net cash provided by operating activities	$	66,155	$	82,447	Net cash provided by operating activities	$	100,437	$	124,209
Net cash used in investing activities	Net cash used in investing activities	(59,813)		(20,977)		Net cash used in investing activities	$	(94,976)	$	(56,195)
Net cash used in financing activities	Net cash used in financing activities	$	(31,916)	$	(7,265)	Net cash used in financing activities	$	(36,869)	$	(28,970)

Operating Activities

Net cash provided by operating activities for the ~~six~~nine months ended ~~June 26,~~September 25, 2021 was primarily attributable to net income of ~~$37.5~~$58.0 million and net non-cash expenses of ~~$51.9~~$77.4 million, further impacted by changes in operating assets and liabilities, as explained below.

Inventories, net, increased ~~$12.7~~$15.9 million to ~~$111.9~~$115.1 million at ~~June 26,~~September 25, 2021, compared to $99.2 million at December 26, 2020, as a result of anticipated projected customer demand. Due to provisions for excess and obsolete inventories of ~~$6.9~~$11.6 million and non-cash restructuring charges to record inventory impairments of $1.3 million, the change in Inventories, net, was further impacted.

Operating lease liabilities increased ~~$7.4~~$5.7 million to ~~$42.1~~$40.4 million at ~~June 26,~~September 25, 2021, compared to $34.7 million at December 26, 2020 as a result of additional right-of-use assets obtained in exchange for lease obligations of ~~$11.6~~$11.7 million offset by lease payments.

Investing Activities

Net cash used in investing activities for the ~~six~~nine months ended ~~June 26,~~September 25, 2021 was primarily related to ~~$31.3~~$51.4 million property, plant and equipment acquisitions, and ~~$28.5~~$43.6 million net cash used to purchase marketable securities.

Financing Activities

Net cash used in financing activities for the ~~six~~nine months ended ~~June 26,~~September 25, 2021 primarily related to $24.0 million used to purchase common stock under our stock repurchase program, ~~$5.3~~$12.6 million related to tax withholding associated with the net share settlements of our equity awards, ~~and $4.7~~$7.0 million of principal payments made towards the repayment of our term loans, and $3.9 million paid to settle the contingent consideration from the acquisition of FRT, partially offset by ~~$5.9~~$10.6 million of proceeds received from issuances of common stock under our employee stock purchase plan and stock option ~~plans, and $3.9 million paid to settle the contingent consideration from the acquisition of FRT.~~plans.

3433

Debt

FRT Term Loan

On October 25, 2019, we entered into a $23.4 million three-year credit facility loan agreement (the “FRT Term Loan”), to fund the acquisition of FRT GmbH, which we acquired on October 9, 2019.

The FRT Term Loan bears interest at a rate equal to the Euro Interbank Offered Rate (“EURIBOR”) plus 1.75% per annum and will be repaid in quarterly installments of approximately $2.0 million plus interest. The interest rate at ~~June 26,~~September 25, 2021 was ~~1.21%~~1.20%. As of ~~June 26,~~September 25, 2021, the balance outstanding pursuant to the FRT term loan was ~~$12.5~~$10.3 million.

Building Term Loan

On June 22, 2020, we entered into an $18.0 million 15-year credit facility loan agreement (the “Building Term Loan”). The proceeds of the Building Term Loan were used to finance the purchase a building adjacent to our leased facilities in Livermore, California.

The Building Term Loan bears interest at a rate equal to the applicable LIBOR rate plus 1.75% per annum. Interest payments are payable in monthly installments over a fifteen-year period. The interest rate at ~~June 26,~~September 25, 2021 was 1.84%. As of ~~June 26,~~September 25, 2021, the balance outstanding pursuant to the Building Term Loan was ~~$17.0~~$16.8 million.

On March 17, 2020, we entered into a forward starting interest rate swap agreement to hedge the interest payments on the Building Term Loan for the notional amount of $18.0 million, and an amortization period that matches the debt. As future levels of LIBOR over the life of the loan are uncertain, we entered into this interest-rate swap agreement to hedge the exposure in interest rate risks associated with movement in LIBOR rates. By entering into the agreement, we ~~convert~~converted a floating rate interest at one-month LIBOR plus 1.75% into a fixed rate interest at 2.75%. As of ~~June 26,~~September 25, 2021, the notional amount of the loan that is subject to this interest rate swap is ~~$17.0~~$16.8 million.

Stock Repurchase Program

In October 2020, our Board of Directors authorized a program to repurchase up to $50.0 million of outstanding common stock to offset potential dilution from issuances of common stock under our stock-based compensation plans. The share repurchase program will expire on October 28, 2022. During the ~~six~~nine months ended ~~June 26,~~September 25, 2021, we repurchased 620,200 shares of common stock for $24.0 million and, as of ~~June 26,~~September 25, 2021, $26.0 million remained available for future repurchases.

Contractual Obligations and Commitments

The following table summarizes our significant contractual commitments to make future payments in cash under contractual obligations as of ~~June 26,~~September 25, 2021:


		Payments Due In Fiscal Year															Payments Due In Fiscal Year
		Remainder 2021		2022		2023		2024		2025		Thereafter		Total			Remainder 2021		2022		2023		2024		2025		Thereafter		Total
Operating leases	Operating leases	$	4,264	$	8,527	$	7,172	$	6,766	$	6,742	$	14,850	$	48,321	Operating leases	$	2,116	$	8,536	$	7,167	$	6,744	$	6,726	$	14,815	$	46,104
Term loans - principal payments	Term loans - principal payments	4,677		9,376		1,050		1,080		1,111		12,259		29,553		Term loans - principal payments	2,302		9,225		1,050		1,080		1,111		12,258		27,026
Term loans - interest payments (1)	Term loans - interest payments (1)	228		364		281		262		240		1,146		2,521		Term loans - interest payments (1)	109		361		280		261		239		1,142		2,392
Total	Total	$	9,169	$	18,267	$	8,503	$	8,108	$	8,093	$	28,255	$	80,395	Total	$	4,527	$	18,122	$	8,497	$	8,085	$	8,076	$	28,215	$	75,522

(1) Represents our minimum interest payment commitments at 1.84% per annum for the Building Term Loan and ~~1.21%~~1.20% per annum for the FRT Term Loan. This also excludes any amounts related to our interest rate swap.

Off-Balance Sheet Arrangements

Historically, we have not participated in transactions that have generated relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of ~~June 26,~~September 25, 2021, we were not involved in any such off-balance sheet arrangements.

3534

Recent Accounting Pronouncements

See Note 1, Basis of Presentation and New Accounting Pronouncements, of Notes to Condensed Consolidated Financial Statements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A “Quantitative and Qualitative Disclosures about Market Risk” contained in Part II of our Annual Report on Form 10-K for the fiscal year ended December 26, 2020. Our exposure to market risk has not changed materially since December 26, 2020.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Controls

Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any control systems must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of a simple error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

CEO and CFO Certifications

We have attached as exhibits to this Quarterly Report on Form 10-Q the certifications of our Chief Executive Officer and Chief Financial Officer, which are required in accordance with the Exchange Act. We recommend that this Item 4 be read in conjunction with the certifications for a more complete understanding of the subject matter presented.

PART II - OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes during the ~~six~~nine months ended ~~June 26,~~September 25, 2021 to the risk factors discussed in our Annual Report on Form 10-K for the year ended December 26, 2020. If any of the identified risks actually occur, our business, financial condition and results of operations could suffer. The trading price of our common stock could decline and you may lose all or part of your investment in our common stock. The risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 26, 2020 are not the only ones we face. Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business operations.

3635

~~Item 2.~~ ~~Unregistered Sales of Equity Securities and Use of Proceeds~~

~~Repurchase of Common Stock~~

~~The following table summarizes our repurchases of outstanding common stock for the three months ended June 26, 2021:~~

Period (fiscal months) Total Number of Shares Purchased Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)
Maximum Amount that May Yet Be Purchased Under the Plans or Programs
March 28, 2021 - April 24, 2021 — $ — — $ 44,261,726
April 25, 2021 - May 22, 2021 438,798 $ 38.07 438,798 $ 27,558,329
May 23, 2021 - June 26, 2021 45,000 $ 33.53 45,000 $ 26,049,418
483,798 37.64 483,798

1 In October 2020, our Board of Directors authorized a program to repurchase up to $50.0 million of outstanding common stock to offset potential dilution from issuances of our common stock under our employee stock purchase plan and equity incentive plan. Under the authorized stock repurchase program, we may repurchase shares from time to time on the open market. The pace of repurchase activity will depend on levels of cash generation, current stock price and other factors. The program may be modified or discontinued at any time. The share repurchase program will expire on October 28, 2022.

Item 6. Exhibits

The following exhibits are filed herewith and this list constitutes the exhibit index.

Exhibit

Incorporated by Reference

Filed

Exhibit

Incorporated by Reference

Filed

Number

Exhibit Description

Form

Date

Number

Herewith

Number

Exhibit Description

Form

Date

Number

Herewith

3.1

Amended and Restated Certificate of Incorporation of the Registrant as filed with the Delaware Secretary of State on June 17, 2003

S-1

October 20, 2003

3.01

3.1

Amended and Restated Certificate of Incorporation of the Registrant as filed with the Delaware Secretary of State on June 17, 2003

S-1

October 20, 2003

3.01

3.2

Amended and Restated Bylaws of the Registrant

8-K

July 22, 2016

3.2

Amended and Restated Bylaws of the Registrant

8-K

July 22, 2016

3.2

31.01

Certification of Chief Executive Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.01

Certification of Chief Executive Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.02

Certification of Chief Financial Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.02

Certification of Chief Financial Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.01

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.01

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101

The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 26, 2021, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags

101

The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 25, 2021, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags

101.INS

XBRL Instance Document

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

104

The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 26, 2021, formatted in Inline XBRL (included as Exhibit 101)

104

The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 25, 2021, formatted in Inline XBRL (included as Exhibit 101)

______________________________________

* This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

3836

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		FormFactor, Inc.

Date:	~~July 30,~~November 2, 2021	By:	/s/ SHAI SHAHAR

			Shai Shahar
			Chief Financial Officer
			(Duly Authorized Officer, Principal Financial Officer, and Principal Accounting Officer)

3937


	Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)		Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)	Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)
Three Months Ended June 26, 2021	$	(203)	Interest expense	$	(39)	Interest expense	$	—
Three Months Ended June 27, 2020	$	(174)	Interest expense	$	(10)	Interest expense	$	—

Six Months Ended June 26, 2021	$	421	Interest expense	$	(77)	Interest expense	$	—
Six Months Ended June 27, 2020	$	(270)	Interest expense	$	12	Interest expense	$	—


	Amount of Gain (Loss) Recognized in Accumulated OCI on Derivative		Location of Gain (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Three Months Ended June 26, 2021	$	278	Cost of revenues	$	134
			Research and development	16
			Selling, general and administrative	52
				$	202

Three Months Ended June 27, 2020	$	52	Cost of revenues	$	(139)
			Research and development	(17)
			Selling, general and administrative	(35)
				$	(191)

Six Months Ended June 26, 2021	$	(248)	Cost of revenues	$	384
			Research and development	46
			Selling, general and administrative	134
				$	564

Six Months Ended June 27, 2020	$	(126)	Cost of revenues	$	(258)
			Research and development	(35)
			Selling, general and administrative	(79)
				$	(372)


Period (fiscal months)	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)	Maximum Amount that May Yet Be Purchased Under the Plans or Programs
March 28, 2021 - April 24, 2021	—	$	—	—	$	44,261,726
April 25, 2021 - May 22, 2021	438,798	$	38.07	438,798	$	27,558,329
May 23, 2021 - June 26, 2021	45,000	$	33.53	45,000	$	26,049,418
	483,798	37.64		483,798